US20110236932A1 - Biopharmaceutical plant in a column - Google Patents

Biopharmaceutical plant in a column Download PDF

Info

Publication number
US20110236932A1
US20110236932A1 US13/125,430 US200913125430A US2011236932A1 US 20110236932 A1 US20110236932 A1 US 20110236932A1 US 200913125430 A US200913125430 A US 200913125430A US 2011236932 A1 US2011236932 A1 US 2011236932A1
Authority
US
United States
Prior art keywords
capsule
capsules
bioreactor
pumping
stream processing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/125,430
Inventor
Per Stobbe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stobbe Tech AS
Original Assignee
Stobbe Tech AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stobbe Tech AS filed Critical Stobbe Tech AS
Assigned to STOBBE TECH A/S reassignment STOBBE TECH A/S ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: STOBBE, PER
Publication of US20110236932A1 publication Critical patent/US20110236932A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04BPOSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B45/00Pumps or pumping installations having flexible working members and specially adapted for elastic fluids
    • F04B45/04Pumps or pumping installations having flexible working members and specially adapted for elastic fluids having plate-like flexible members, e.g. diaphragms
    • F04B45/053Pumps having fluid drive
    • F04B45/0536Pumps having fluid drive the actuating fluid being controlled by one or more valves
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/34Internal compartments or partitions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/42Integrated assemblies, e.g. cassettes or cartridges
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/14Scaffolds; Matrices
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04BPOSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B43/00Machines, pumps, or pumping installations having flexible working members
    • F04B43/0009Special features
    • F04B43/0081Special features systems, control, safety measures
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04BPOSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B43/00Machines, pumps, or pumping installations having flexible working members
    • F04B43/02Machines, pumps, or pumping installations having flexible working members having plate-like flexible members, e.g. diaphragms
    • F04B43/06Pumps having fluid drive
    • F04B43/073Pumps having fluid drive the actuating fluid being controlled by at least one valve
    • F04B43/0733Pumps having fluid drive the actuating fluid being controlled by at least one valve with fluid-actuated pump inlet or outlet valves; with two or more pumping chambers in series
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04BPOSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B43/00Machines, pumps, or pumping installations having flexible working members
    • F04B43/02Machines, pumps, or pumping installations having flexible working members having plate-like flexible members, e.g. diaphragms
    • F04B43/06Pumps having fluid drive
    • F04B43/073Pumps having fluid drive the actuating fluid being controlled by at least one valve
    • F04B43/0736Pumps having fluid drive the actuating fluid being controlled by at least one valve with two or more pumping chambers in parallel
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04BPOSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B49/00Control, e.g. of pump delivery, or pump pressure of, or safety measures for, machines, pumps, or pumping installations, not otherwise provided for, or of interest apart from, groups F04B1/00 - F04B47/00
    • F04B49/06Control using electricity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00Means for introduction, extraction or recirculation of materials, e.g. pumps
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04BPOSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B49/00Control, e.g. of pump delivery, or pump pressure of, or safety measures for, machines, pumps, or pumping installations, not otherwise provided for, or of interest apart from, groups F04B1/00 - F04B47/00
    • F04B49/08Regulating by delivery pressure

Definitions

  • the present invention relates to a set of therapeutic material multifunctional processing highly flexible devices stacked in a column, hereby creating a process plant with extremely small foot-print and where preferably all processing devices are of single-use capabilities in order to obtain lowest possible costs.
  • the present invention also relates to methods for continued operation of said bioreactor.
  • Disposable bioreactors were considered a novelty, and perhaps even a passing trend, as recently as mid 90ties.
  • the development of disposable bioreactors and filters is, in many instances, driven by reduction in sterilisation and cleaning requirements, improved plant flexibility, reduced costs and faster time to market for the end product. Recently, all of these benefits have been well documented.
  • the future hurdles to be overcome include the ability to add reliable, accurate, low cost sensors and pumping devices so that standards can be generated and the process repeatability readily documented.
  • a single-use stacked system provides a high degree of flexibility for biotech process design with a minimum of foot-print for reduced facility cost. It allows the practitioner to faster evaluate different configurations before deciding on the final design. Then, should the batch size be modified, or new requirements evolve, the system can be modified more easily to fit with new requirements. If also the single-use technology is available in all sizes like from small, clinical batches to full production scale further costs are reduced.
  • the main advantage of single-use are elimination of the preparation steps involved with stainless steel kit, such as cleaning, assembly, and disassembly, autoclaving and “clean-in-place” (CIP) or “sterilize-in-place” (SIP) operations, as well as associated labour, and validation costs and material costs.
  • CIP clean-in-place
  • SIP sterilize-in-place
  • Biopharmaceutical system which is made up of different process step units such as for example a downstream pre-purification unit, an upstream media conditioning unit, and a pump unit kept together in a stack can be developed, build and implemented in weeks, rather than months.
  • Such a complete plant-in-a-stack should be suited for all Biopharmaceutical systems, which manufacture all types of drugs: monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives and small molecules, such as anti-cancer drugs.
  • the present invention however is not limited to drug manufacturing. Also production of enzymes, vaccines, food ingredients or like is possible. Such technology is particularly well suited for CMOs (Contract Manufacturing Organizations), where a number of different products can be produced and the key issues are flexibility and avoiding cross-contamination.
  • the Stax platform from the US based company Pall and the Zeta-Plus system from Cuno/3M offer both a holding system for bench-top as well as floor size for stacking of micro-filtration and depth filtration capsules.
  • the present invention solves the problem of how to improve the flexibility of a bioreactor by providing a number of capsules serving different purposes for the bio-reaction taken place in the bioreactor.
  • the capsules are easily assembled in a stack.
  • a bioreactor providing the optimal solution for producing a particular chemical compound is easily developed.
  • the present invention also solves the problem of how to optimize the size of the bioreactor by providing a reactor with increased “compactness”, which reduces the cost of manufacturing production facilities needed for industrial scale bio-fermentation.
  • the invention is a single-use Biopharmaceutical Plant or bio factory assembled from a number of individual capsules and stacked into a column.
  • the column operate on continues basis with in lifetime strictly opposite to the batch process.
  • Such column comprises individual capsules which integrate individual devices such as;
  • the above six groups each allow for many variations of performance and technical art though all being preferably of disposable character, which eliminates the costly CIP, SIP processes and the associated validation procedure.
  • the stack of the present invention which includes high cell density bioreactor capsules, further reduces the size requirements to the white room facilities. Operation mode based on the bio factory according to the present invention and its capsules integrated therein offers quite extraordinary possibilities, which so far are unknown in the industry.
  • a bioreactor comprising interconnected, stackable capsules, wherein one or more cell cultivation capsule(s) is separating two pumping capsules capable of regulating the diversion of a feeding liquid to and from said cell cultivation capsule, said bioreactor optionally further comprising one or more pre-separation capsules, one or more sparging capsules, one or more diffusion capsules, one or more manifold capsules, wherein a pumping capsule is located at each end of the stack.
  • the capsules present in between the two pumping capsules may be stacked individually in any order and any number, with the proviso that the top capsule and the bottom capsule in the column must be pumping capsules.
  • a bioreactor factory device comprising a production unit for cultivating biological cells and for producing one or more chemical compounds and optionally a down stream processing unit.
  • the production unit comprises at least three capsules, which are interconnected and stacked.
  • the three mandatory capsules of the production unit is a bioreactor capsule, and two pumping capsules designated first pumping capsule and second pumping capsule.
  • the first pumping capsule is always positioned as the top capsule and the second pumping capsule is always positioned as the bottom capsule in the production unit. Consequently, a bioreactor capsule is always separating the first and the second pumping capsule.
  • the first and the second pumping capsule are in operable and liquid contact with each other and are capable of regulating the diversion of a feeding liquid to and from the bioreactor capsule.
  • the number of bioreactor capsules present in the bioreactor unit may be any number, which is necessary in order to produce the amount of chemical compound during the period of time available for the manufacture.
  • the number may lie in the range of 1 to 50 capsules such as for instance 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 or 50.
  • the production unit of the bioreactor factory also comprises at least one conditioning capsule.
  • This capsule may be located at any position between the first and the second pumping capsule, i.e. on any side of the bioreactor capsule(s) as well as in between bioreactor capsules in cases where more than one bioreactor capsule is present in the bioreactor unit.
  • At least one of the conditioning capsule(s) is a temperature regulating capsule.
  • This temperature capsule may be capable of increasing the temperature of the liquid media flowing through the production unit and in other embodiments the capsule may be capable of decreasing the temperature of the liquid media flowing through the production unit.
  • the number of temperature regulating capsules may take any number depending on the heating/cooling capacity of the capsule and dependent on the amount of heat to be generated or consumed due to the biochemical reaction taken place inside of the bioreactor unit. Typically the number of temperature regulating capsules lies in the range of 1 to 20, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20.
  • At least one of the conditioning capsule(s) is a diffusion capsule.
  • This capsule takes the function of supplying oxygen to the media circulating through the bioreactor unit so that the oxygen consumed by the action of the microorganisms is continuously replaced by fresh oxygen.
  • the number of diffusion capsules present in the bioreactor unit depends on the microorganisms in the bioreactor capsule and on the type of biochemical reaction occurring in the reactor. Typically the number of diffusion capsules lies in the range of 1 to 20, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20.
  • At least one of the conditioning capsule(s) is a pH-regulating capsule.
  • a pH-regulating capsule may be necessary in cases where acid or bases are produced during the biochemical reaction due to the action of microorganism, but also in cases where the microorganisms are very sensitive for any changes in the pH of the media, it may be necessary to monitor and regulate the pH continuously.
  • the number of pH-regulating capsules lies in the range of 1 to 20, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20.
  • At least one of the conditioning capsule(s) is a combined diffusion and pH-regulating capsule, i.e. both supply of oxygen and regulation of pH takes place in the same capsule.
  • This combination may be beneficial in cases where pH is regulated by supplying gases such as for example CO2 to the liquid media flowing through the reactor.
  • gases such as for example CO2
  • the incorporation of two functions into one capsule also improves the compactness of the reactor.
  • the number of combined diffusion and pH-regulating capsules lies in the range of 1 to 20, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20.
  • the bioreactor further comprises one or more capsules for providing fresh nutrient liquid to the production unit it must be noted, however, the supply of fresh media may take place in any of the capsules, as long as the capsule is fitted with an inlet port, through which the fresh media can enter.
  • the number of capsules for providing fresh nutrient liquid lies in the range of 1 to 20, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20.
  • the production unit of the bioreactor factory further comprises one or more pumping capsule(s) located at any position between the first and the second pumping capsule.
  • the total number of capsules in the production unit is significant, such as for example more than 5, it may be necessary to incorporate one or more pumping capsules in order to be able to pump the liquid through the production unit at essential same velocity at any place within the production unit.
  • the number of additional pumping capsules lies in the range of 1 to 20, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules and at least one temperature regulating capsule.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules and at least one diffusion capsule.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules and pH-regulating capsule.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules and diffusion and pH-regulating capsule.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules and at least one capsule for providing fresh media.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least three pumping capsules and at least one down stream processing capsule.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one temperature regulating capsule and at least one diffusion capsule.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one temperature regulating capsule and at least one pH-regulating capsule.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one temperature regulating capsule and at least one diffusion and pH-regulating capsule.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one temperature regulating capsule and at least one diffusion and at least one capsule for providing fresh media.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least three pumping capsules, at least one temperature regulating capsule and at least one down stream processing capsule.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one diffusion capsule and at least one pH-regulating capsule.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one diffusion capsule and at least one diffusion and pH-regulating capsule.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one diffusion capsule and at least one capsule for providing fresh media.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least three pumping capsules, at least one diffusion capsule and at least one down stream processing capsule.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one pH-regulating capsule, and at least one diffusion and pH-regulating capsule.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one pH-regulating capsule and at least one capsule for providing fresh media.
  • the bioreactor factory device consists of'at least one bioreactor capsule, at least three pumping capsules, at least one pH-regulating capsule and at least one down stream processing capsule.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one diffusion and pH-regulating capsule and at least one capsule for providing fresh media.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least three pumping capsules, at least one diffusion and pH-regulating capsule and at least one down stream processing capsule.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one temperature regulating capsule, at least one diffusion, at least one pH-regulating capsule, and at least one capsule for providing fresh media.
  • the bioreactor factory device consists of at least one bioreactor capsule, at least three pumping capsules, at least one temperature regulating capsule, at least one diffusion, at least one pH-regulating capsule, at least one capsule for providing fresh media, and at least one down stream processing capsule.
  • the bioreactor factory device consists of at least one pumping capsule, at least one bioreactor capsule, at least one conditioning capsule, at least one diffusion capsule, at least one surface separation capsule, at least one valve capsule.
  • the order of capsules is: pumping capsule, bioreactor capsule(s), conditioning capsule(s), diffusion capsule(s), surface separation capsule(s), valve capsule(s) and pumping capsule(s).
  • the bioreactor factory device does not contain a temperature regulating capsule.
  • the bioreactor factory device does not contain a diffusion capsule.
  • the bioreactor factory device does not contain a pH-regulating capsule.
  • the bioreactor factory device does not contain a diffusion and pH-regulating capsule.
  • the bioreactor factory device does not contain a capsule for providing fresh media capsule.
  • At least one of the capsules in the production unit is advantageously fitted with one or more sensors.
  • sensors are optical sensors.
  • the bioreactor factory device also comprises a down stream processing unit placed inside the column.
  • the down stream processing unit comprises at least one down stream processing capsule and at least one pumping capsule.
  • the bioreactor factory device the down stream processing unit is placed outside the column.
  • the bioreactor factory device do not comprise a down processing unit since such down stream processing is not necessary for the collection of the chemical compound of interest
  • the production unit and the down stream processing unit may be placed in any order as compared to one another.
  • the production unit is positioned on top of the down stream processing unit.
  • a pumping capsule must be positioned as the bottom capsule of the down stream processing unit.
  • the down stream processing unit is positioned on top of the production unit, in which case a pumping capsule is positioned as the top capsule of the down stream processing unit.
  • one pumping capsule is always positioned as the top capsule and another pumping capsule is always positioned as the bottom capsule in the bioreactor factory device.
  • the down stream processing capsule may perform any separation method which is known in the art.
  • the choice of down stream processing process depends on the chemical compound of interest, which is to be isolated as well as the chemical and physical properties of the media from which the chemical compound is to be removed.
  • the down stream processing capsule is selected from the group consisting of a membrane filtration capsule, a separation capsule, a ion exchange capsule, a purification capsule, a chromatography capsule, an activated carbon capsule, and a packed bed capsule.
  • the down stream processing capsule comprises a flow-through matrix made up of a number of tubes through which the liquid to be processed is flowing.
  • the compound of interest is separated from the liquid due to the action of the tubes, for example by being bound to the wall inside the tube by chemical or physical interaction.
  • the capsule is constructed similar to the capsule shown in FIG. 8 .
  • the capsules may be supplied with means for exchanging liquids and information and the like.
  • the capsules of the bioreactor is further provided with interlocking interface areas for exchange of fluid, electrical signals, electrical power, pneumatic signal exchange and/or vacuum signal exchange.
  • the capsules of the bioreactor are further provided with interlocking means, such as latches, for keeping together the capsules in the stack.
  • a sealing arrangement may be covering the capsules during storage and stacking the capsules and then removed after stacking but before a the capsules in the stack is forced together, preferably by use of the interlocking means.
  • the mode of operation is also flexible. Consequently, in one embodiment the capsules in the stack are placed in the horizontal position next to one another, and in another embodiment the stack of capsules are placed in the upright position vertical to one another.
  • Yet another aspect of the present invention provide a method for cultivating micro organisms and/or producing a chemical compound by use of a biochemical reaction taken place in the bioreactor as described above.
  • FIG. 1 A column assembled from 3 bioreactor capsules and two pumping capsules, one pumping capsule at each end of the bio reactor capsule in opposite position facing the bioreactor.
  • FIG. 2 A pumping capsule with details of the diaphragm and two designs of valves
  • FIG. 3 A bioreactor capsule with ten fibrous matrix discs
  • FIG. 4 A down stream processing capsule with eighteen depth filter discs
  • FIG. 5 A manifold capsule with valves
  • FIG. 6 A conditioning capsule with heating element
  • FIG. 7 A conditioning capsule with cooling or sparging tubular element
  • FIG. 8 A diffusion capsule for various gases or filtration, separation purposes
  • FIG. 9 An extended column comprising two bioreactor capsules, one down stream processing capsule, three pumping capsules, one manifold capsule, and two conditioning capsules
  • FIG. 10 The stack in principle, and principle fluid circuit diagram
  • Stacking may be performed by arranging the capsules next to each other in a pivoting holder system and the capsules in the stack may be interconnected by use of fluid exchange flange seals and kept together by use of clamps with such a force that the seals insure liquid tight performance.
  • the numbers of capsules to be stacked are at least three and the stack could be as high as 2 meter.
  • the design of the preferred disposable capsules may be of tangential flow principle, radial flow principle, cross flow principle with symmetric or asymmetric porous bioreactor matrix design and either of round design, rectangular or combinations thereof.
  • the capsules may comprise channels for cooling or heating within the capsule structure, and the capsules may also comprise sanitary flange fittings such as tri-clamp or the common industrial 25 mm port for sensor, electrode connections.
  • the size of the capsules is not limited, but may be such as 12 or 16 inches or as the capsules shown in the figures, which are of ⁇ 442 mm in diameter. Sizes of the invented capsule designed column could match sizes in the industry like 12 or 16′′ being a diameter standard from 3Ms CUNO or Pall STAX product line. Capsules could even be of size like from 100 mm up to 1000 mm in diameter. For a bench-top column diameter of 150 mm and height of 400 mm results in a weight of less than 20 kilo. For a production column designed with ⁇ 442 mm diameter and 1500 mm height the total weight is less than 100 kilo and the bottom control capsule support the column to a wheel base, which also allows easy transportation within the production facility premises.
  • the capsule concept according to the present invention preferably combines communication along the column, such as wires, hoses, etc for transmission of signals for processing purposes or tasks for actuators to perform.
  • Very compact and passive manifold capsules with no valves are commercially available with tri-clamp inlet and outlet flanges, which allow fluid connection to any of the capsules of the present invention.
  • the bioreactor capsules, or cassettes, of the present invention may be combined in the same commercial filter pivoting holder system with similar sized filtration capsules, or cassettes for cell culture product clarification.
  • the proposed set-up is a very compact solution and will enable the manufacturer to cut production cost and facility size further.
  • FIG. 9 illustrates a 1.7 meter high bio factory system with in total 9 capsules of which two are bioreactor capsules and one is a down stream processing capsule.
  • the single-use, pre-sterilized capsule or cassette concept allows for fast exchange, development, variable capacity and small foot print.
  • Yet another variation of the present invention provides non round capsules or cassettes with at least one fluid inlet and at least one fluid outlet integrated within the capsules design.
  • Such as the Plate & Frame design an expression for old fashion assembling of a larger number of cassettes into a holder system with the typically square or rectangular plates, which typically operate in parallel. Also known as “filter presses” or “membrane plate filters” in the industry.
  • filter presses or “membrane plate filters” in the industry.
  • a very common principle in the filtration industry and the design, column principle may be used for the bioreactor of the present invention.
  • the present invention also relates to the capsule design with interlocking mechanical clamp, means such as latches, which allow two or more individual capsules to be locked together fully independently of the known holding systems.
  • the interlocking mechanical means is preferably based on two or more solid stainless steel rods, one rigid end plate and one movable top plate including a threaded arrangement to tighten the stacked capsules.
  • the present invention eliminates the problems of contaminating the lab or production facility when being disassembled for disposal after use. Disassembling a stack of capsules filled with contaminant should in no way be exposed to the facilities, but rather be directly disposed of.
  • the single-use capsules assembled into larger set-up could be stacked within a horizontal pivoting holder system and the stack is then removed from this tool after assembly.
  • the present invention avoids permanent use of stainless steel holding, pivoting systems.
  • Breakable seal in foil may cover the complete capsules end surface. Breakable seal in foil is covering each individual through going, fluid connector, manifold, flange for interconnections and protects the surface of the capsules from the surroundings. The capsules are stacked and the integrity seals are removed by pulling the seal in a radial direction exposing the two fluid connections to each other ready for interfacing. Use of seals on capsules is relevant on both bench-top systems and larger floor mounted systems. Bench-top systems could alternatively be delivered pre-assembled from the supplier.
  • Two capsules end face foil seals facing each other protect a sterilized and gas protected surface, internal devices and connections.
  • the foil is double in a design where the outer foil is equipped with a handle and a 180 degree bend opposite of the handle. When the handle is pulled the sealing foil will slip the circumference attachment. When two capsule seals are removed simultaneously no contamination reaches the fluid connection and gas connection. Also a slight overpressure of protective gas in each capsule insures no contamination is sucked into the capsules.
  • a thin foil seal is integrated and glued on the circumference for protection purposes, and cover the entire end face and all the fluid flanges.
  • Each capsule is to be connected without rotation to the next capsule controlled by a simple pair of male and female tracks located in a non-symmetrical mode on the capsule circumference outside the cover seal, which allow capsules of the column to be assembled without breaking the seals and prohibit incorrect orientation.
  • the foil is to be broken when two capsules are correctly positioned towards each other exposing fluid connection, gas connection, electrical connectors rotational correct oriented towards the neighbouring capsule.
  • the foils are removed simultaneously by dragging both foils of in a double mode configuration without exposing any end face to the local environment. After seal removal the two capsules need to be forced and pushed together for positive connection with latches.
  • two or more different designed columns preferably work together and are connected internally with hoses via the tri-clamp port system.
  • One column primarily assembled from bioreactor capsules, conditioning enclosed by at least one pumping capsule in each end.
  • the sister column contains a number of desirable down stream processing capsules and two to three pumping capsules.
  • the pump & valve control capsule allow via its communication bus to connect all data transfer with PLC or PC.
  • bioreactor or “bioreactor capsule” also refers to a packed bed reactor chamber or a reactor which employs flow of biological cell culture and/or feeding liquid medium there through and which may be used for the growth of cell cultures or for packing with suitable support materials or matrices, such as, for example and without limitation, beads in the micrometer or millimetre scale (diameter), micro-spheres in general, micro-carriers, and the like, to which cells or cell colonies or cellular components can be attached or on which individual, isolated enzymes or enzyme systems can be immobilized for reaction with selected substrates.
  • suitable support materials or matrices such as, for example and without limitation, beads in the micrometer or millimetre scale (diameter), micro-spheres in general, micro-carriers, and the like, to which cells or cell colonies or cellular components can be attached or on which individual, isolated enzymes or enzyme systems can be immobilized for reaction with selected substrates.
  • the bioreactor of the present invention may also comprise a continuous, integrated membrane system.
  • the cells are confined between two membranes which form a cell chamber, at least one of which is preferably microporous and hydrophilic and permits free passage of nutrients present in a feeding liquid.
  • the bioreactor capsules may comprise a plurality of permeable discs.
  • the permeable disc of the present invention preferably does not contain or comprise a monolith, such as a ceramic thin wall, multi channel, and parallel channel monolith.
  • the permeable disc of the present invention preferably does not contain or comprise microspheres, such as e.g. essentially spherical beads.
  • the discs according to the present invention can be of any form and shape.
  • the discs are circular with an optionally cut-out central portion to allow for the adaptation of a feeding tube or a collection reservoir in operable contact with the discs.
  • the height i.e.
  • thickness of the discs is preferably less than 500 millimeters, such as preferably less than 400 millimeters, for example preferably less than 350 millimeters, such as preferably less than 300 millimeters, for example preferably less than 250 millimeters, such as preferably less than 200 millimeters, for example preferably less than 150 millimeters, and preferably more than 1 millimeter, such as more than 2 millimeters, for example more than 5 millimeters, such as preferably more than 8 millimeters, for example preferably more than 10 millimeters, such as preferably more than 12 millimeters, for example preferably more than 14 millimeters, such as preferably more than 16 millimeters, for example preferably more than 18 millimeters, such as preferably more than 20 millimeters, for example preferably more than 22 millimeters, such as preferably more than 24 millimeters, for example preferably more than 26 millimeters, such as preferably more than 28 millimeters, for example preferably
  • the diameter of the discs (including the optionally cut-out, central portion) will depend on the reactor design, including the height of the discs, and the disc diameter is, in one embodiment, preferably less than 500 centimeters, such as less than 480 centimeters, for example less than 460 centimeters, such as less than 440 centimeters, for example less than 420 centimeters, such as less than 400 centimeters, for example less than 380 centimeters, such as less than 360 centimeters, for example less than 340 centimeters, such as less than 320 centimeters, for example less than 300 centimeters, such as less than 280 centimeters, for example less than 260 centimeters, such as less than 240 centimeters, for example less than 220 centimeters, such as less than 200 centimeters, for example less than 190 centimeters, such as less than 180 centimeters, for example less than 170 centimeters, such as less than 160 centimeter
  • the permeable disc fibres preferably has, in one embodiment, an average diameter in the range of from 0.01 micrometer to preferably less than 100 micrometers, such as an average fibre diameter of from 0.05 to preferably less than 100 micrometers, for example an average fibre diameter of from 0.10 to preferably less than 100 micrometers, such as an average fibre diameter of from 0.15 to preferably less than 100 micrometers, for example an average fibre diameter of from 0.20 to preferably less than 100 micrometers, such as an average fibre diameter of from 0.25 to preferably less than 100 micrometers, for example an average fibre diameter of from 0.50 to preferably less than 100 micrometers, such as an average fibre diameter of from 1.0 to preferably less than 100 micrometers, for example an average fibre diameter of from 2.0 to preferably less than 100 micrometers, such as an average fibre diameter of from 4.0 to preferably less than 100 micrometers, for example an average fibre diameter of from 6.0 to preferably less than 100 micrometers, such as an average fibre diameter of from 8.0 to preferably less than 100 micrometer
  • the packing density of the permeable disc fibres is preferably, in one embodiment, in the range of from 100 to 5000 gram/meter2, such as from 100 to 200 gram/meter2, for example from 200 to 300 gram/meter2, such as from 300 to 400 gram/meter2, for example from 400 to 500 gram/meter2, such as from 500 to 600 gram/meter2, for example from 600 to 700 gram/meter2, such as from 700 to 800 gram/meter2, for example from 800 to 900 gram/meter2, such as from 900 to 1000 gram/meter2, for example from 1000 to 1100 gram/meter2, such as from 1100 to 1200 gram/meter2, for example from 1200 to 1300 gram/meter2, such as from 1400 to 1500 gram/meter2, for example from 1500 to 1600 gram/meter2, such as from 1700 to 1800 gram/meter2, for example from 1800 to 1900 gram/meter2, such as from 1900 to 2000 gram/meter2, for example from 2000 to 2100 gram/meter2, such as from 2100 to 2200 gram/meter2,
  • the volume of the open cells/pores of the matrix of the permeable discs/stacks is preferably less than 95% of the volume of the disc/stack itself, such as preferably less than 90%, for example less than 85%, such as less than 80%, for example less than 75%, such as less than 70%, for example less than 65%, such as less than 60%, for example less than 55%, such as less than 50%, for example less than 45%, such as less than 40%, for example less than 35%, such as less than 30%, for example less than 25%, such as less than 20%, and preferably more than 5%, for example more than 10%, such as more than 15% of the volume of the disc/stack itself.
  • the number of permeable discs/stacks present in the bio-reactor, or a capsule thereof can be any number, preferably a number of from 2 to 100, such as 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 and 100.
  • the bioreactor of the present invention may according to one embodiment comprise a porous matrix, one or more bio-reactor inlet port(s) and one or more bio-reactor outlet port(s),
  • said matrix is suitable for anchoring and/or supporting the cultivation of living cells or micro organism in general
  • said matrix separates said one or more bio-reactor inlet port(s) from said one or more bio-reactor outlet port(s),
  • said matrix comprises individual matrix sections each separated by a spacer section for diverting feeding liquid to or from said individual matrix sections.
  • Each of such “individual matrix section” can comprise a plurality, as for example at least 2, “individual matrix sub-sections”, wherein each such sub-section is separated from another sub-section by a permeable layer comprising a plurality of openings exerting a biological cell retaining function, but not a feeding liquid retaining function, wherein the diameter of the openings of the permeable layer is smaller than the diameter of the biological cells to be cultivated, thereby creating a layer in between individual matrix sub-sections which is capable of diverting feeding liquid in a direction essentially perpendicular to the direction in which feeding spacers and drainage spacers are diverting feeding liquid to and from, respectively, the individual matrix sections.
  • the thickness of an individual “permeable layer”, or the collective thickness of a plurality of “permeable layers” dividing an individual matrix section into a plurality of sub-sections, is preferably less than 10% of the thickness of the individual matrix section comprising said one or more permeable layer(s).
  • the one or more permeable layer(s) preferably divide an individual matrix section into sub-sections having at least essentially similar thicknesses, i.e. no sub-section differs in thickness by more than 10% from any other individual matrix sub-section.
  • the permeable layer(s), when present, ensures that feeding liquid can flow from a feeding liquid spacer either through the individual matrix sections, or through the permeable layer, thereby further reducing and/or eliminating gradients of feeding liquid nutrients in the bio-reactor.
  • the flow rate of feeding liquid along the permeable layer will be faster than the flow rate of feeding liquid through the individual matrix parts.
  • the flow along flow rate of feeding liquid along the permeable layer will be slower than the flow rate of feeding liquid through the individual matrix parts. Under such practical circumstances the feeding liquid being diverted along the permeable layer can be regarded as a supplemental source of feeding liquid useful for obtaining and sustaining optimal biological growth conditions.
  • a bio-reactor comprising a plurality of permeable discs comprising a matrix comprising a plurality of fibres defining a plurality of inter-connected, open cells or pores extending through at least part and preferably all of each disc,
  • biological cells are capable of adhering to the fibres and capable of residing in at least some and preferably all of the inter-connected, open cells,
  • each feeding spacer section provides feeding liquid to each of a first set of two adjacently located, permeable discs and so that each drainage spacer section receives feeding fluid from each of a second set of two, adjacently located, permeable discs
  • each disc is contacted by one feeding spacer section and one drainage spacer section, respectively, on opposite sides of the disc,
  • the first set of two adjacently located, permeable discs and the second set of two adjacently located, permeable discs have one disc in common when the feeding spacer section and the drainage spacer section are positioned next to each other in the bio-reactor, i.e. when they contact opposite surfaces of one and the same disc.
  • each disc The overall flow of a feeding liquid through each disc is essentially in a direction which is perpendicular to the direction of the flow of feeding liquid along the feeding spacer section feeding said disc, i.e. the matrix material of the disc exerts a “cross-flow” effect on the feeding liquid.
  • feeding liquid exits a disc it is diverted along the drainage spacer section in a direction which is also essentially perpendicular to the direction of flow of feeding liquid through the disc.
  • the open cells or pores of the matrix of the permeable discs are larger in diameter than the biological cells to be cultivated, thereby allowing said cells to reside in said open cells during all or part of the duration of the fermentation.
  • the bio-reactor can be fitted with a suitable pump in order to ensure the a desirable flow rate is obtained.
  • the bio-reactor can also be fitted with sensors and a control unit for controlling the seeding of cells and the progression of the subsequent fermentation.
  • a bio-reactor comprising a plurality of permeable discs or stacks comprising a matrix comprising a plurality of fibres defining a plurality of inter-connected, open cells or pores extending through at least part and preferably all of each disc,
  • biological cells are capable of adhering to the fibres and capable of residing in at least some and preferably all of the inter-connected, open cells,
  • each feeding spacer section provides feeding liquid to each of two adjacently located, permeable discs and so that each drainage spacer section receives feeding fluid from each of two, adjacently located, permeable discs
  • a plurality of permeable discs comprising a matrix comprising a plurality of fibres defining a plurality of inter-connected, open cells or pores extending through at least part and preferably all of the disc
  • biological cells are capable of adhering to the fibres and capable of residing in at least some of the inter-connected, open cells
  • each feeding spacer section provides feeding liquid to each of two adjacently located, permeable discs and so that each drainage spacer section receives feeding fluid from each of two, adjacently located, permeable discs
  • one or more axially elongated feeding tubes comprising a plurality of openings through which feeding liquid can be diverted to each of the plurality of permeable discs
  • feeding liquid can be diverted from said one or more feeding tubes to said plurality of feeding spacers through said holes of said one or more feeding tubes
  • each feeding spacer is not connected to an outlet port for diverting feeding liquid to a collection reservoir
  • each feeding spacer separates two adjacently positioned permeable discs
  • feeding liquid can be diverted from each of said plurality of feeding spacers and through a pair of neighbouring, permeable discs separated by a feeding spacer to one or more drainage spacers,
  • each drainage spacer is not connected to a feeding tube hole
  • each but end-positioned drainage spacer(s) separates two adjacently positioned permeable discs
  • a wall section comprising a plurality of collection reservoir outlet ports
  • each collection reservoir outlet port is in liquid contact with a collection reservoir
  • a collection reservoir for collecting feeding liquid diverted to said collection reservoir from the permeable discs via drainage spacers and through said collection reservoir outlet ports.
  • a number of different designs of heat exchangers for cooling or heating, which are commercial available for temperature regulations, may be used and incorporated into the bioreactor stack of the present invention in order to control the temperature of the liquid flowing through the bioreactor.
  • the fermentation or micro organism activity is typically an exothermic process generating heat.
  • the volume/surface ratio of the reactor is decisive for weather heat must be applied or removed.
  • For insect cells the required process temperature lies in the range of 27-28 degree Celsius and for mammalian cells the needed temperature is around 37 degree Celsius.
  • the fluid from an external temperature conditioning devise is constantly circulated in the fluid-conditioning capsule controlling the stack temperature. More than one temperature conditioning capsule may be suited for a high stack.
  • Temperature regulation could also be done with integrated Peltier elements, which are able to either cool or heat depending on how the DC poles are connected to the two element connections.
  • Heating is performed preferably by the heating element cast located in suitable plastics.
  • the product Bekinox which is available from the Belgium company Bekaert, could also be incorporated in the conditioning capsule.
  • cell cultures are aerated with multiple gases such as oxygen, nitrogen, CO 2 , and air in a mixture, which is specific for each type of micro organism and the specific fermentation process.
  • Gas composition is regulated by sensitive control systems, and an optimum gas atmosphere should be formed and maintained for the fermentation and manufacture of the product.
  • pH control could be done by adding acids and bases as it is done in bacterial fermentations but preferably addition of CO 2 is controlling the pH.
  • the supply gases are usually accomplished from an external mounted gas-mixing station.
  • the dosage of each gas is controlled by the comprehensive control capacity included in the pump & valve controller.
  • the pump & valve controller regulates pH by adding dosages of CO 2 and the O 2 control regulates the aeration with air or Oxygen and Nitrogen.
  • the amount of dissolved Oxygen (dO) is limited by the low solubility of oxygen in aquatic buffers and media.
  • dO dissolved Oxygen
  • cells demand 10-14 to 10-13 mole oxygen per cell per hour and therefore efficient oxygen transfer for high dell density fermentations is critical.
  • sparging with air/oxygen bubbles can efficiently transfer oxygen to the medium, such bubbles can cause severe damage to the cells.
  • Cultivated mammalian cells are damaged by air-liquid interfaces due to the interaction with gas bubbles. Therefore a bubble free diffusion capsule with gas transfer by diffusion is most efficient.
  • Other micro organisms are much more tolerant to bubbles.
  • the diffusion materials are typically:
  • the media supply capsule receives new nutrient, and optionally various gases preferably in concentrated form and is supplied dilute into the re-circulating fluid according to the information send from sensors on a real-time basis and prediction all controlled by the PLC within the pump & valve controller.
  • the pH and O 2 adjustment may take place in separate individual capsules or both adjustments may take place in the same capsule.
  • Supply of fresh nutrient liquid may take place in any of the capsules in the biofactory or the supply may occur in a separate capsule.
  • the first step after the bioreactor (production unit) of the retentate flow is the down stream processing or pre-clarification or product clarification.
  • Many desirable principles are well-known without being necessary practical to utilize.
  • FIG. 8 illustrate such a situation as the invented multi-channel containing capsule combined with pumping capsule ( FIG. 2 ) and manifold capsule ( FIG. 5 ) facilitates operation after the Tangential Flow Filtration (TFF), also known as Cross Flow Filtration (CFF) principles.
  • TFF Tangential Flow Filtration
  • CFF Cross Flow Filtration
  • the product flow (such as feed after bioreactor) is directed tangentially along the surface of a hollow fibre membrane with most of the solution circulated back to the feed storage as retentate.
  • the high velocity cross flow creates a pressure drop, which forces some of the feed solution and dissolved molecules that are smaller than the pores in the membrane, through the membrane filter.
  • the solution that passes through the membrane is referred to as filtrate or permeate. Molecules or particles larger than the membrane pores are retained in the feed solution and effectively concentrated.
  • the fluid dynamics of cross flow filtration reduces membrane fouling and maintains filtration rates (flux) for a longer period of use, thus increasing membrane throughput (greater capacity) compared to traditional cartridge (direct flow) filtration.
  • the high velocity feed solution along the membrane surface acts to ‘sweep’ the surface, reducing concentration polarization (product concentration at the membrane surface). It also prevents build-up of foulants that can plug the pores at the membrane surface.
  • the membrane module is exposed to a fluid pulse in the opposite direction, a back-flushing pulse, which helps remove potential build up on the feed flow side of the membrane. All such methods are well known within the filtration industry.
  • EXT SP is an open-grade medium that serves as an upstream or pre-filter that can replace centrifugation for small ( ⁇ 200 L) batches.
  • EXT ZA media are of tighter grade and hold a strongly positive resin for removal of host cell proteins and DNA.
  • Centrifuging is less of a required process as the producing micro organism is kept stationary, contained in bioreactor capsule. Down stream the bioreactor a depth filter may efficiently trap, capture the low levels of cell debris, impurities in the harvest stream. Modem depth filters can be effectively employed in an adsorptive capacity for the capture of soluble impurities in addition to their conventional use in clarifying particle moderate fluid streams.
  • the present invention is designed to replace energy-consuming centrifuges in a biotech process. Centrifuges are after all not single use, difficult to scale up and require a high effort for cleaning, cleaning validation and maintenance.
  • Chromatography separation which relies on membrane separation, depends partly on pressure drop, as to the extremely small pore size, somewhat higher, ranging pressures of 100-300 kPa. This technique and method is well within the reach of being of disposable character and hereby possible to introduce into the invented column.
  • Another final purification step of increased interest is separation by suspension crystallization based on freezing with refrigerants equipment temperature capacity ranging to minus 60 degree Celsius.
  • the crystalliser converts the feed into a slurry of pure product crystals and the residual mother liquor.
  • the cooling takes place in one column being a part of a loop where the crystal growth and separation takes place in a separate column before traditional mechanical device compresses the slurry to remove the mother liquor and form a packed crystal bed.
  • This bed consists of the pure product crystals surrounded by some residual mother liquor.
  • the equipment for this process is large, depends on materials, which eliminate that the technology becomes easily of disposable character. Companies like GEA, Sulzer and other offer such equipment.
  • Another final purification step includes high frequency resonant ultrasonic waves to separate cells instead of a physical mesh or membrane, which offers all the benefits of traditional devices but without their inherent problems and limitations.
  • Technology based on acoustic resonance is a non fouling/non clogging retention system offered by company Applikon from The Netherlands. A technique well within the reach of being disposable and hereby possible to introduce into the invented column.
  • the present invention comprises a capsule integrated reciprocating diaphragm pump based on single-use materials, single diaphragm pumping device, operating from absolute pressure to over atmospheric pressure, in its most simple form with electronically control by micro processor connected to various sensors and pneumatics operated valves, which are also present in the fluid streams.
  • a preferred design of a pumping capsule is shown in FIG. 2 .
  • the pumping capsule contains the electronics and pneumatics for pump and valve control.
  • the capsules PCB may include provisions for internal data acquisition along the control power supply, which are all based on micro processors.
  • the column capsules may integrate single-use sensors, wiring, and connectors in order to transmit data with the PCB. The column performance and integrity benefit from extended data acquisition capabilities from external mounted sensors of various specification and use.
  • the control unit capsule may further have provisions for control of stand-alone pumps, valves or other devices outside of the column or mounted on one or more of the flanges found on the capsule circumference.
  • the pumping capsule or the manifold capsule may have provisions in order to remove entrapped gasses like air from the column start-up. The requirement of pressure relief valve is less of a problem as the fluid pressures are monitored on a real-time base at various location in the capsules, column.
  • Manifold capsules serve several purposes such as with active valves as seen in FIG. 5 comprising four identical valves of which two are in contact with the inner centre tube and the two other valves with the fluid ring tube around the centre.
  • the expandable tube valves are inserted in the capsule body and integrated with flanges outside at the circumference. Valves shown here are pneumatic driven and needs to communicate with the pump & valve control capsule devices intended for such application.
  • the manifold capsule allows alternative drainage or feed, and access to fluids from the two centre fluid passages, which are not accessible by the pumping capsule.
  • Any of the embodiments of the present invention may include passageways incorporated for correspondence with traditional electrochemical 12 mm diameter sensors probes for monitoring. Sensors as supplied from Hamilton, Mettler-Toledo, and others with Pg 13.5 thread are used in the industry and inserted in ports via sealed connections.
  • bioreactor may be placed in a bag of flexible materials or in cassettes, capsules or the like from non flexible materials, which allow the bioreactor to be single-use and disposable. It is advantageous to avoid introduction of any foreign articles such as standard electrochemical 12 mm diameter sensors probes, transmitters after bioreactor sterilization. Such sensors will not accept the sterilization or they loose their calibration. Relevant real-time sensors are such as for those measurements of gases, dissolved gases, liquids, temperature, cell density, organics, pressures, etc.
  • the present invention benefits from disposable sensors which may be integrated into the bioreactor bag or capsule.
  • Optical sensors have the advantages that they can be engineered to be non-invasive or introduced into the bioreactor before gamma sterilization occurs, do not have stringent grounding requirements, and can often provide enhanced perkimance over existing chemical or electrochemical methods.
  • a variety of sensors principles are used; chemical-optical, optical, fluorescence, near infrared spectroscopic—NIR, Partial Least Squares—PLS, Principal Component Analysis—PCS, radio frequency impedance.
  • Compact single-use sensors are manufactured by the German company PreSens Precision Sensing GmbH being flat to less than 1-5 mm, less than 50 mm in diameter with wires or electrical connectors extending from the sensor. Or the sensor elements are attached to the inside of bioreactor corresponding through the translucent container material to a transmitter on the outside for non-invasive and non-destructive operation.
  • An alternative product is manufactured by Finesse Corp from USA who offers a line of disposable optical sensors for detection of dissolved oxygen and pH.
  • Waste products such as lactate and NH4+accumulate and the culture degenerates during the run. This can lead to the production of proteases and other degradation enzymes, which can act on the desired product. Also, key nutrients may become exhausted. Since the conditions within the culture may be constantly changing, cells go through several phases of growth, peaks, and troughs of production, and product may be degraded prior to harvest.
  • perfusion mode media and other nutrients are continuously exchanged and product is harvested throughout the culture period.
  • Perfusion mode operation allow for continued fermentation and constant harvest.
  • the bioreactor is operated in a configuration basically with one inlet and one outlet. The majority of the fluid flow volume is constantly passing the bioreactor capsule and re-circulated. A minor flow is continuously drained including the product and processed separately and outside of the bioreactor. A similar volume is added as fresh nutrient including oxygen addition. As no head space is required and the oxygenation is done outside the reactor foaming is not a problem.
  • the process operates as a chemostat with cell retention, where the constant addition of fresh medium and the elimination of waste products provide the cells with the stable environment they require.
  • a bioreactor factory device comprising similar diameter and individual height capsules stacked into a column, said capsules being of different purposes such as:
  • pumping capsules bioreactor capsules, pre-separation capsules, filtration capsules, storage capsules, conditioning capsules, sparging capsules, diffusion capsules, manifold capsules, column end capsules able to be stacked individually in any order and any number with the proviso that the top capsule and the bottom capsule in the column must be pumping capsules.
  • a bioreactor factory capsule with fluid, electrical, pneumatic connections to neighbouring capsules encapsulating either a; pump, and/or a bioreactor and/or a filtration device, or an electronically control device for the above.
  • a bioreactor factory device of cylindrical capsules comprising interlocking interface areas on each end face of said cylindrical capsule for fluid, electrical signal, electrical power, pneumatics, vacuum signal exchange.
  • a bioreactor factory device comprising similar diameter and individual height capsules stacked into a column comprising interlocking mechanism locking each capsule fluid tight and mechanical stable to each of its neighbour capsules.
  • a bioreactor factory capsule sealing arrangement on each side of the capsules insuring sterile handling to be pulled of when interconnecting the capsules into a stack of at least two capsules.
  • a column of bioreactor factory capsules according to any of the previous items, stacked, interlocked with and kept in a holding system comprising at least two stainless steel bars in parallel with the centre axis of the capsules for floor use.
  • a column of bioreactor factory capsules according to any of the previous items, stacked and interlocked with a holding system comprising at least two stainless steel bars in parallel with the centre axis of the capsules for bench top use.
  • Nutrient flow being prepared externally by adding Glucose, amino acids or the like to the re-circulating fluid, which furthermore contain oxygen introduced via diffusion of oxygen . or air from externally mounted membrane based devices for a nutrient solution suitable for feeding the bio micro organism.
  • the reactor inlet flow volume is larger than the reactor permeate flow outlet with at least 10% and the cross retentate, reactor outlet flow is externally re-circulated by a pump to the reactor inlet and kept at selected pressure.
  • the bioreactor product volume, which is included in the permeate volume, is regulated by an external valve or positive displacement pump in order to obtain the desired flow over the bioreactor matrix keeping the fresh nutrient flow gradient below 5% over the matrix.
  • a bioreactor device according to any of the previous items having disposable sensors, probes integrated.
  • FIG. 1 illustrates the capsule assembling principle at its most simple configuration with non visible latches on the circumference frame for inter locking purposes.
  • the configuration is shown in 3D perspective.
  • Each capsule end-face is designed to exchange fluids with the neighbour capsule end-face. It is, however, also possible to exchange gases, electrical supply, data communication and sensor information via wires, hose integrated in the circumference wall.
  • the capsules are of identical diameter (in all the illustration of ⁇ 442 mm) for simple inter connection and preferably designed in several different heights named UH (one Unit Height in the illustration is 128 mm), such as:
  • Each of the three bioreactor capsules ( 111 , 112 , 113 ) is identical and mounted independently of each other. As each capsule has a female and a male connector in the circumference an adaptor is needed between the bottom pumping capsule 14 a and the bottom bioreactor capsule ( 111 ) to compensate for the fact that the bottom pump in capsule ( 14 a ) is turned. opposite.
  • Each of the two pumping capsules 14 a, 14 b have four identical valves ( 12 a, 13 a ) and external ports ( 12 , 13 ) (only half is visible) through the circumference and internal port to the diaphragm ( 11 ) fluid volume ( 11 a ).
  • the pumping capsules ( 14 a, 14 b ) house two integrated valves, which operate fully independently of each other in the capsule centre and connect the diaphragm volume to any other capsule fluid interface. All six valves in each pumping capsule ( 14 a, 14 b ) operate fully independently of each other and are pneumatically controlled from the PCB below the diaphragm. More details are seen in FIG. 2 .
  • FIG. 1 No sensors are shown in FIG. 1 , but all sensors present are preferably of single-use capabilities.
  • the illustrated set-up will work excellent in perfusion mode, when connected to an external supply of fresh media as well as to the purification devices.
  • No external pumps are needed as the two integrated diaphragm pumps also handle the external circulation of fluids.
  • FIG. 2 illustrates a preferred embodiment of a pumping capsule in 3D perspectives with the major four parts drawn apart from each other for better understanding. The same pumping capsule is also seen in FIGS. 1 and 9 in the present text.
  • fluid control devices such as actuators for valves on PCB ( 60 d )
  • Control capsule cover ( 20 c ) primary (not disposable) parts are:
  • the pump capsule shell ( 20 a ) is a disposable housing parts manufactured from plastics. At least one circular end-face integrated dual element valve ( 29 ) with dimensions according to the purification capsules platform including both inlet and outlet. As to the advantage of fluid communication with purification and/or other capsules the axial dual Naive elements ( 29 a, 29 b ) opens or closes according to need for fluid access from the capsules connected to internal fluid volume ( 21 a ).
  • the upper housing part facilitate the central valve embodiment ( 29 ) and several valve embodiments ( 22 a, 23 a ) pointing perpendicular to the central axis from said concave pumping chamber ( 21 a ) to the circumference of the upper housing part ( 20 a ) for external fluid communication.
  • the valve bodies is elastic tube sleeves ( 23 b ), which inflated by pneumatic pressure added to outer side of the tube sleeve, force the tube to collapse around a central core part ( 23 c ) locking for any fluid flow through the valve.
  • the lower housing part ( 20 b ) supports mechanically the pumping diaphragm ( 21 ) during maximum inflation with a concave upper housing part ( 20 a ) with the lower housing part ( 20 b ) for deflation further facilitating support for at least one displacement sensor ( 24 ), pressure sensor(s), and temperature sensor.
  • Displacement sensor ( 24 ) based on laser principles able to measure the distance to and the position of the membrane ( 21 ) and absolute pressure sensors based on micro electronics, both with a flexible transparent window on the wall in order to separate the two different environments.
  • the control capsule ( 20 c ) contains on the circuit board ( 20 d ) the entire package of electronics, sensors and controls.
  • Proportional valve(s) for diaphragm control, on/off valves for the tube sleeve valves, and micro processor including connections the driving gas inlet/outlet on the circumference.
  • FIG. 3 illustrates a preferred embodiment of a bioreactor capsule to be placed in a column.
  • the bioreactor matrix disc capsules is situated inside a stackable capsule device ( 30 ) of rigid disposable materials with at least one fluid inlet ( 32 a ) and a series of symmetrically placed fluid outlets ( 32 b ) integrated axially within the design of capsules ( 30 ).
  • Four radial oriented fluid outlet ports ( 32 b ) are connected to drainage collection volume ( 33 ) at the capsules periphery.
  • the bioreactor capsule design comprises at least one set of matrix discs ( 31 ) and as here illustrated five sets of matrix discs ( 31 ).
  • the forced fluid flow is introduced at one of two inlet ( 32 a ) filling up the inlet volume ( 32 ), and distributed to four full size and two half size feed spacer entrance ( 35 a ) radial filling the feed spacer volume by laminar flow at overpressure flowing perpendicular to the entire surface area of at least one matrix disc.
  • the fluid then flows through the disc ( 31 ) to the drainage spacer volume ( 35 b ) and then further radial into the circumference collection volume ( 33 ), to be conveyed to end face collection volume ( 36 ) and outlet ( 32 b ).
  • More than one bioreactor capsule may be mounted on top of each other and work in parallel and be sealed by ( 30 a ) covering both inlet ( 32 a ) and exit ( 32 b ).
  • the fluid may optionally pass further to at least one pumping capsule, a conditioning capsule, a separation capsule, etc.
  • FIG. 4 illustrates a preferred embodiment of a down stream processing capsule ( 40 ) comprising a number of traditional fibre based depth filter thin discs ( 41 ) oriented in sets angled to each other.
  • a down stream processing capsule 40
  • eighteen identical discs ( 41 ) are positioned inside the capsule ( 40 ).
  • eight double step latches (not shown) are mounted and spread symmetrically around the capsule circumference for capsule assembling, which makes it easy to tightly keep the capsules together.
  • Two dual fluid connections ( 42 a, 42 b ) one at each end face are incorporated for connection to the neighbouring capsules.
  • Fluid from the vertical inlet volume ( 42 ) guides flow through perforated tube ( 42 c ) to the inlet volume of the depth filter discs ( 41 ).
  • Circumference collection volume for drainage fluids guides liquid to either of the end face flanges and through port ( 42 b ).
  • FIG. 5 illustrates a preferred embodiment of a manifold capsule ( 50 ) having four identical expandable tube sleeve valves ( 56 a, 56 c ), ( 56 b and 56 d are inside tubes in the capsule and hence not shown), which are operated by pressurized air supplied by a pump unit (not shown) via hoses ( 52 h ). On/off valves (not shown) either close or leave the valves open.
  • Two external tri-clamp flanges connections 52 a, 52 b ) are connected with the centre tube ( 55 ) and the other two flanges ( 52 c, 52 d ) are connected with the fluid ring slot ( 54 ) around the centre tube ( 55 ).
  • a rubber seal ( 57 ) insure leakage free connection to the interface similar neighbouring platform capsules.
  • FIG. 6 illustrates one embodiment of designing a conditioning capsule ( 60 ) with heating capabilities.
  • the electrical heating elements are fully covered with approved materials and formed into four heating discs ( 61 a, 61 b, 61 c, 61 d ) with fluid contact on each side, divided into two set ( 61 a, 61 b ) and ( 61 c, 61 d ) of discs in order to increase surface contact to the fluid that passes.
  • the specific surface roughness or sets of ribs may be introduced in order to increase contact area and guide the fluid direction.
  • multiple circular slots ( 65 ) for fluid passage in the heating discs ( 61 a, 61 b, 61 c, 61 d ) insures improved turbulence and contact between fluid and heating element discs.
  • All heating discs ( 61 a, 61 b, 61 c, 61 d ) are connected electrically to the plug ( 64 ) on the outside of the circumference of the capsule ( 60 ).
  • Preferably at least one of the heating discs has a temperature sensor element integrated.
  • Fluid inlet ( 61 a ) and fluid outlet ( 61 b ) may be interchanged, i.e. in some embodiments the fluid may enter the capsule through ( 61 b ) and leave the capsule through ( 61 a ).
  • Two extra tri-clamps ports ( 63 a, 63 b ) allow for various connections.
  • FIG. 7 illustrates one embodiment of designing a conditioning capsule ( 70 ) with symmetrically end face fluid connections and cooling capabilities.
  • the stacked non porous wall tube heat exchanger coils ( 71 ) are located inside the capsule ( 70 ) with tube connection via two integrated tri-clamp flanges ( 74 a, 74 b ) on the outside of the circumference of the capsule.
  • the fluid flow path is labyrinth fluid flow created by three flat discs ( 75 ) between the coils. Two discs fixed to the centre inlet perforated tube, one disc fixed to the capsule circumference. Fluid inlet ( 71 a ) is used on both sides to convey the fluid. Two extra tri-clamps ( 73 a, 73 b ) allow for sensor connections.
  • the capsule will also work as a sparging capsule (preferably combined with a bioreactor capsule with a need for oxygenation) with porous tubes coiled as shown and pressurized gases like air or oxygen inside the tube.
  • FIG. 8 shows a preferred embodiment of a capsule concept, which by design is suitable for several purposes, such as for various surface filtration and separations or diffusion purposes.
  • the capsule is an oxygenation capsule ( 80 ), which may be incorporated for the purpose of real-time adjustment of the oxygen content in the media as dissolved oxygen and/or as micro bubbles.
  • the shown capsule integrates a capsule ( 81 ) for oxygen introduction, which is short and quite wide.
  • the circular design is easy to integrate in the round capsule ( 80 ).
  • Oxygen or air pressure is applied from the circumference and surrounds the multiple gas-permeable hoses/tubes/fibres ( 81 a ) between the epoxy end faces ( 81 b, 81 c ) and gas exchange, diffusion takes place through the fibre wall with the fluid in both directions.
  • the media flows in axial direction with inlet from any of the end faces to the distribution chamber with access to the numerous numbers of gas-permeable tubes.
  • the fluid are forced by pumping actions through the tubes to the opposite side and into collection chamber and further conveyed to the exit flange.
  • Two connection flanges ( 83 a, 83 b ) allow connection to valves (not shown) preferably controlled by the pumping capsules of either pneumatic or electric character. This feature makes it possible to adjust, in real-time, the supply of various gases and in particular oxygen, and the adjustment is controlled from within the column.
  • the shown capsule offers a maximum of 5.7 m 2 surface area from 4,000 single hollow fibres tubes each being ⁇ 5 mm and 90 mm long effective.
  • the figure shows one single gas-permeable hoses/tube/fibre capsule, but in case of a relatively large diameter the capsule could be made up of a number of smaller units placed in parallel within the same capsule.
  • FIG. 9 shows an embodiment of the invented bio factory capsules stacked into a column ( 90 ) including the individual capsules as described above.
  • the column comprises two bioreactor capsules ( 912 , 913 ) similar to the capsule shown in FIG. 3 , one down stream processing capsule ( 97 ) similar to the capsule shown in FIG. 4 , three pumping capsules ( 94 a, 94 b, 94 c ) similar to the capsule shown in FIG. 2 , two conditioning capsules ( 95 , 96 ) similar to the capsules shown in FIGS. 6 , 7 and 8 , respectively, and one manifold capsule ( 98 ) similar to the capsule shown in FIG. 5 .
  • 9 provides unlimited methods of use and includes specific connections in form of short hoses outside the stack between capsules, which facilitate the desired flow distribution along the column ( 90 ).
  • An appropriate number of the capsules are equipped with external fluid connection flanges of tri-clamp design on the circumference.
  • the illustrated set-up is appropriate for mammalian cell cultivation.
  • the column contains nine capsules and has a height of approx 1.7 meter.
  • the single-use capability capsules are of identical diameter and platform concept in order to provide simple interconnection.
  • the capsules are preferably designed in several different chassis heights in order to permit incremental capacity increase. Most of the capsules are able to perform bottom-up, to-down, bottom-in, and bottom-out.
  • the easily interchangeable capsules in the bioreactor of FIG. 9 are:
  • Bioreactor capsules 911 , 912
  • Conditioning capsule ( 96 ) including three ports for additional sensors ( 96 a )
  • Down stream processing capsule in this example being one depth filtration capsule ( 97 )
  • the two bioreactor capsules ( 911 , 912 ) are stacked on top of and next to the diffusion capsule ( 95 ) and together with the capsule below, (i.e. the temperature, fresh media and extra gas conditioning capsule 96 ), the passive production unit is provided.
  • the pumping capsule 94 a completes the active production unit, which is capable of operating independently of the down stream processing unit, which is made up of a down stream processing capsule ( 97 ) and a manifold capsule ( 98 ) and a pumping capsule ( 94 c ).
  • the diffusion capsule ( 95 ) On the circumference of the diffusion capsule ( 95 ) is mounted two flanges ( 95 a, 95 b ) for access to gases such as CO2, air, and oxygen from an external supply to the inner core consisting of a hollow fibre capsule ( 95 c ).
  • gases such as CO2, air, and oxygen from an external supply to the inner core consisting of a hollow fibre capsule ( 95 c ).
  • Fresh media in diluted or concentrated form may be introduced via one of several ports on either side of the conditioning capsules controlled by a valve.
  • the two pumping capsules ( 94 a, 94 b ) are able to service unlimited tasks of fluid communication requirements internal in the production unit as well as with external devices or any combinations thereof.
  • the down stream processing unit consist in the present illustration of one depth filtration capsule ( 97 ) on top of one manifold capsule ( 98 ) combined with one pumping capsule ( 94 c ).
  • This independent down stream processing unit is operational on stand alone conditions also outside the FIG. 9 column.
  • only one down stream processing capsule ( 97 ) is shown. It is, however, possible to include several down stream processing capsules driven by the pump within the same column. Aseptic connection of two or more columns is done by sterile hoses externally via the generous use of tri-clamp flanges in order to perform the desired procedure of operation (not shown—see FIG. 10 ).
  • FIG. 10 shows a circuit diagram of the assembly in FIG. 9 .
  • all capsules integrate single-use sensors for monitoring at least oxygen temperature and pH values.
  • the extra tri-clamp flanges on some capsules facilitate the use of any sensor.
  • the present figure illustrates the integration principle of the bioreactor capsule ( 101 ), which on the reactor top is connected to a in bottom-up position pumping capsule ( 104 b ) and on the reactor bottom side is connected to two conditioning capsules ( 105 , 106 ), which are further connected to one pumping capsule 104 a.
  • a pump control valve On the rear side of each pumping capsules a pump control valve is located, which is shown as a wide black cross. Any of the interconnected pumping capsules ( 104 a, 104 b, 104 c ) is able to work simultaneously, in tandem, individually and without any restriction in timing and reasonable flow capability.
  • the manifold capsule ( 108 ) is controlled by the pumping capsule ( 104 c ) control unit.
  • a manifold capsule ( 108 ) connects the down stream processing capsule ( 107 ) with a port for drainage of product through valve ( 109 b ).
  • the inlet to the down stream processing capsule ( 107 ) is positioned centrally at top of pumping capsule ( 104 c ) through the central of the manifold capsule ( 108 ). All fluid is fed through the pumping capsule ( 104 a ). Air drainage during start up is done through valve on pumping capsule ( 104 b ) via port ( 109 k ).
  • Fresh nutrient liquid is added through valve ( 109 a ) and sucked into the pump chamber of pumping capsule ( 104 a ), as the diaphragm is deflated, from an external volume corresponding to the product volume drained under pressure from pump ( 104 c ) through port ( 109 b ).
  • the dual in-line valve ( 109 c ) of the centre of pumping capsule ( 104 a ) conveys the main nutrient flow pressurized by inflating diaphragm in ( 104 a ) through the conditioning capsules ( 106 ) and ( 105 ) to the bioreactor capsule ( 101 ). Then the fluid passes the bioreactor ( 101 ) from inside volume ( 109 d ) to the circumference collection volume ( 109 e ) passing and through dual central valve ( 109 f ) located in pumping capsule ( 104 b ) while simultaneously the diaphragm in pumping capsule ( 104 b ) is deflated.
  • the flow is conveyed in a radial flow pattern from the central core inlet ( 109 d ), through the matrix discs for collection at the circumference volume ( 109 e ) and directed through the ring inlet valve part of dual central valve ( 109 f ) located in the pumping capsule ( 104 b ).
  • Nutrient liquid is re-circulated from pumping capsule ( 104 b ) through tube ( 109 g ) on the right side of bioreactor ( 101 ) to pumping capsule ( 104 a ) through an inlet valve, and the flow pattern as described above is repeated.
  • the down stream processing capsule ( 107 ) only collects a small amount of active micro organisms, because the majority of micro organisms are anchored in the bioreactor capsules ( 101 ).
  • the down stream processing capsule ( 107 ) collects continuously dead cells and other particles as to the perfusion mode circulation and allows the purified product to pass.
  • a selected fraction of the retentate volume may be drained via drainage valve ( 109 b ) directly from down stream processing capsule ( 107 ), the retentate fluid volume being equivalent to the fresh nutrient volume being added at ( 109 a ).
  • pumping capsule ( 104 b ) will direct fluid to pumping capsule ( 104 c ) through tube line ( 109 h ) and through central valve ( 109 i ), which forces the fluid to pass the down stream processing capsule ( 107 ) to drainage valve ( 109 b ) as product.
  • the conditioning capsule ( 105 ) receives pressurized sterile gases to be dissolved, and sparged into the fluid through valve ( 109 j ).
  • the cross-flow conditioning capsule ( 106 ) contains temperature conditioning devices to insure correct bioreactor temperature.
  • Seeding with micro organism is done after the column is completely filled with media.
  • the fluid is conditioned by re-circulation of the fluid for some time, which will insure collection of entrapped gas to be emptied via port ( 109 k ) by allowing pump ( 104 a ) or ( 104 b ) to suck the culture media into the pumping chamber and force the seeding fluid up through the conditioning capsule into the bioreactor for anchoring.
  • the seeding is performed through ( 109 m ) into pump ( 104 b ) and reversed directly down through centre of dual valve ( 109 f ) into the centre volume ( 109 d ) of bioreactor capsule ( 101 ).
  • the single-use, pre-sterilized, disposable capsule devices which are assembled in column configuration, provides significant product expression improvements, very small foot-print, low-cost investment, elimination of CIP, SIP and offer easy of use. Further all capsules communicate with the common PLC for the whole stack with several close loop control algorithms performing the desired routines.

Abstract

The present invention relates to a series of therapeutic material processing devices stacked into a column, hereby creating a bio material process plant with extremely small foot-print and all the processing devices being of single-use capabilities for lowest possible cost and methods of operating said column.

Description

    TECHNICAL FIELD
  • The present invention relates to a set of therapeutic material multifunctional processing highly flexible devices stacked in a column, hereby creating a process plant with extremely small foot-print and where preferably all processing devices are of single-use capabilities in order to obtain lowest possible costs. The present invention also relates to methods for continued operation of said bioreactor.
  • BACKGROUND OF THE INVENTION
  • Disposable bioreactors were considered a novelty, and perhaps even a passing trend, as recently as mid 90ties. As single-use bioreactors and filters have matured and begun to address most of these issues, their market acceptance has rapidly expanded. The development of disposable bioreactors and filters is, in many instances, driven by reduction in sterilisation and cleaning requirements, improved plant flexibility, reduced costs and faster time to market for the end product. Recently, all of these benefits have been well documented. The future hurdles to be overcome include the ability to add reliable, accurate, low cost sensors and pumping devices so that standards can be generated and the process repeatability readily documented.
  • A single-use stacked system provides a high degree of flexibility for biotech process design with a minimum of foot-print for reduced facility cost. It allows the practitioner to faster evaluate different configurations before deciding on the final design. Then, should the batch size be modified, or new requirements evolve, the system can be modified more easily to fit with new requirements. If also the single-use technology is available in all sizes like from small, clinical batches to full production scale further costs are reduced.
  • The main advantage of single-use are elimination of the preparation steps involved with stainless steel kit, such as cleaning, assembly, and disassembly, autoclaving and “clean-in-place” (CIP) or “sterilize-in-place” (SIP) operations, as well as associated labour, and validation costs and material costs.
  • So a Biopharmaceutical system, which is made up of different process step units such as for example a downstream pre-purification unit, an upstream media conditioning unit, and a pump unit kept together in a stack can be developed, build and implemented in weeks, rather than months.
  • Because of the reduced requirements for validation (including cleaning and sterilization) and the ease of manufacturing, process steps can be developed very quickly. Single-use technology will help speed up the process development and installation of manufacturing process line, which reduces the time to market the product produced in the biopharmaceutical system.
  • Preferably such a complete plant-in-a-stack should be suited for all Biopharmaceutical systems, which manufacture all types of drugs: monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives and small molecules, such as anti-cancer drugs. The present invention however is not limited to drug manufacturing. Also production of enzymes, vaccines, food ingredients or like is possible. Such technology is particularly well suited for CMOs (Contract Manufacturing Organizations), where a number of different products can be produced and the key issues are flexibility and avoiding cross-contamination.
  • Any size of bio factory involves typically the following process steps:
      • Fermentation
      • Product harvesting
      • A first and second clarification, purification with membrane filters
      • Sterile filtration with membrane filters
      • polishing with membrane, resins chromatography
      • storage
    PRIOR ART
  • The Stax platform from the US based company Pall and the Zeta-Plus system from Cuno/3M offer both a holding system for bench-top as well as floor size for stacking of micro-filtration and depth filtration capsules.
  • There is no such thing available on the market or described in the patent literature, as disposable bioreactors or disposable fluid pumps, sensors, heating, conditioning, sparging devices, oxygenating devices integrated into capsules for stacking purposes into a bio factory.
  • Today's process steps are exclusively performed with individually and non-integrated bioreactors, filter, purification devices, pumps, valves, sensors, containers, etc.
      • Reference is made to patent EP 317874A2 from Miles Inc in USA describing a method for continuous production and removal of a biological substance. Though depending on externally separation devices like outside the hollow fibre reactor and not in the column as the present invention explain.
      • Reference is also made to U.S. Pat No. 6,544,424 by Refined Technologies, which describes a filtration system.
    DESCRIPTION OF THE INVENTION
  • The present invention solves the problem of how to improve the flexibility of a bioreactor by providing a number of capsules serving different purposes for the bio-reaction taken place in the bioreactor. The capsules are easily assembled in a stack. By selecting a particular combination of different capsules stacked in a predetermined sequence, a bioreactor providing the optimal solution for producing a particular chemical compound is easily developed.
  • The present invention also solves the problem of how to optimize the size of the bioreactor by providing a reactor with increased “compactness”, which reduces the cost of manufacturing production facilities needed for industrial scale bio-fermentation.
  • The invention is a single-use Biopharmaceutical Plant or bio factory assembled from a number of individual capsules and stacked into a column. The column operate on continues basis with in lifetime strictly opposite to the batch process. Such column comprises individual capsules which integrate individual devices such as;
      • 1. Bioreactor capsules
      • 2. Temperature conditioning capsules
      • 3. pH, O2,and gas conditioning capsules
      • 4. Down stream processing capsules, such as depth, surface, separation, ion exchange and purification devices
      • 5. Pumping capsules
      • 6. Sensors of re-usable and/or single-use capability
  • The above six groups each allow for many variations of performance and technical art though all being preferably of disposable character, which eliminates the costly CIP, SIP processes and the associated validation procedure. The stack of the present invention, which includes high cell density bioreactor capsules, further reduces the size requirements to the white room facilities. Operation mode based on the bio factory according to the present invention and its capsules integrated therein offers quite extraordinary possibilities, which so far are unknown in the industry.
  • It is one aspect of the present invention there is provided a bioreactor comprising interconnected, stackable capsules, wherein one or more cell cultivation capsule(s) is separating two pumping capsules capable of regulating the diversion of a feeding liquid to and from said cell cultivation capsule, said bioreactor optionally further comprising one or more pre-separation capsules, one or more sparging capsules, one or more diffusion capsules, one or more manifold capsules, wherein a pumping capsule is located at each end of the stack. The capsules present in between the two pumping capsules may be stacked individually in any order and any number, with the proviso that the top capsule and the bottom capsule in the column must be pumping capsules.
  • Another aspect of the present invention provides a bioreactor factory device comprising a production unit for cultivating biological cells and for producing one or more chemical compounds and optionally a down stream processing unit. The production unit comprises at least three capsules, which are interconnected and stacked. The three mandatory capsules of the production unit is a bioreactor capsule, and two pumping capsules designated first pumping capsule and second pumping capsule. The first pumping capsule is always positioned as the top capsule and the second pumping capsule is always positioned as the bottom capsule in the production unit. Consequently, a bioreactor capsule is always separating the first and the second pumping capsule. Furthermore, the first and the second pumping capsule are in operable and liquid contact with each other and are capable of regulating the diversion of a feeding liquid to and from the bioreactor capsule.
  • The number of bioreactor capsules present in the bioreactor unit may be any number, which is necessary in order to produce the amount of chemical compound during the period of time available for the manufacture. The number may lie in the range of 1 to 50 capsules such as for instance 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 or 50.
  • In one embodiment the production unit of the bioreactor factory also comprises at least one conditioning capsule. This capsule may be located at any position between the first and the second pumping capsule, i.e. on any side of the bioreactor capsule(s) as well as in between bioreactor capsules in cases where more than one bioreactor capsule is present in the bioreactor unit.
  • In one embodiment at least one of the conditioning capsule(s) is a temperature regulating capsule. This temperature capsule may be capable of increasing the temperature of the liquid media flowing through the production unit and in other embodiments the capsule may be capable of decreasing the temperature of the liquid media flowing through the production unit. The number of temperature regulating capsules may take any number depending on the heating/cooling capacity of the capsule and dependent on the amount of heat to be generated or consumed due to the biochemical reaction taken place inside of the bioreactor unit. Typically the number of temperature regulating capsules lies in the range of 1 to 20, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20.
  • In one embodiment at least one of the conditioning capsule(s) is a diffusion capsule. This capsule takes the function of supplying oxygen to the media circulating through the bioreactor unit so that the oxygen consumed by the action of the microorganisms is continuously replaced by fresh oxygen. The number of diffusion capsules present in the bioreactor unit depends on the microorganisms in the bioreactor capsule and on the type of biochemical reaction occurring in the reactor. Typically the number of diffusion capsules lies in the range of 1 to 20, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20.
  • In one embodiment at least one of the conditioning capsule(s) is a pH-regulating capsule. Such a capsule may be necessary in cases where acid or bases are produced during the biochemical reaction due to the action of microorganism, but also in cases where the microorganisms are very sensitive for any changes in the pH of the media, it may be necessary to monitor and regulate the pH continuously. Typically the number of pH-regulating capsules lies in the range of 1 to 20, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20.
  • In one embodiment at least one of the conditioning capsule(s) is a combined diffusion and pH-regulating capsule, i.e. both supply of oxygen and regulation of pH takes place in the same capsule. This combination may be beneficial in cases where pH is regulated by supplying gases such as for example CO2 to the liquid media flowing through the reactor. The incorporation of two functions into one capsule also improves the compactness of the reactor. Typically the number of combined diffusion and pH-regulating capsules lies in the range of 1 to 20, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20.
  • In some cases it may be necessary or beneficial to supply fresh nutrient liquid to the production unit during operation. Consequently, in one embodiment the bioreactor further comprises one or more capsules for providing fresh nutrient liquid to the production unit it must be noted, however, the supply of fresh media may take place in any of the capsules, as long as the capsule is fitted with an inlet port, through which the fresh media can enter. Typically the number of capsules for providing fresh nutrient liquid lies in the range of 1 to 20, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20.
  • In one embodiment the production unit of the bioreactor factory further comprises one or more pumping capsule(s) located at any position between the first and the second pumping capsule. In cases where the total number of capsules in the production unit is significant, such as for example more than 5, it may be necessary to incorporate one or more pumping capsules in order to be able to pump the liquid through the production unit at essential same velocity at any place within the production unit. Typically the number of additional pumping capsules lies in the range of 1 to 20, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules and at least one temperature regulating capsule.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules and at least one diffusion capsule.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules and pH-regulating capsule.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules and diffusion and pH-regulating capsule.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules and at least one capsule for providing fresh media.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least three pumping capsules and at least one down stream processing capsule.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one temperature regulating capsule and at least one diffusion capsule.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one temperature regulating capsule and at least one pH-regulating capsule.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one temperature regulating capsule and at least one diffusion and pH-regulating capsule.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one temperature regulating capsule and at least one diffusion and at least one capsule for providing fresh media.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least three pumping capsules, at least one temperature regulating capsule and at least one down stream processing capsule.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one diffusion capsule and at least one pH-regulating capsule.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one diffusion capsule and at least one diffusion and pH-regulating capsule.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one diffusion capsule and at least one capsule for providing fresh media.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least three pumping capsules, at least one diffusion capsule and at least one down stream processing capsule.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one pH-regulating capsule, and at least one diffusion and pH-regulating capsule.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one pH-regulating capsule and at least one capsule for providing fresh media.
  • In one embodiment the bioreactor factory device consists of'at least one bioreactor capsule, at least three pumping capsules, at least one pH-regulating capsule and at least one down stream processing capsule.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one diffusion and pH-regulating capsule and at least one capsule for providing fresh media.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least three pumping capsules, at least one diffusion and pH-regulating capsule and at least one down stream processing capsule.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least two pumping capsules, at least one temperature regulating capsule, at least one diffusion, at least one pH-regulating capsule, and at least one capsule for providing fresh media.
  • In one embodiment the bioreactor factory device consists of at least one bioreactor capsule, at least three pumping capsules, at least one temperature regulating capsule, at least one diffusion, at least one pH-regulating capsule, at least one capsule for providing fresh media, and at least one down stream processing capsule.
  • In one embodiment the bioreactor factory device consists of at least one pumping capsule, at least one bioreactor capsule, at least one conditioning capsule, at least one diffusion capsule, at least one surface separation capsule, at least one valve capsule. In yet another embodiment the order of capsules is: pumping capsule, bioreactor capsule(s), conditioning capsule(s), diffusion capsule(s), surface separation capsule(s), valve capsule(s) and pumping capsule(s).
  • In one embodiment the bioreactor factory device does not contain a temperature regulating capsule.
  • In one embodiment the bioreactor factory device does not contain a diffusion capsule.
  • In one embodiment the bioreactor factory device does not contain a pH-regulating capsule.
  • In one embodiment the bioreactor factory device does not contain a diffusion and pH-regulating capsule.
  • In one embodiment the bioreactor factory device does not contain a capsule for providing fresh media capsule.
  • In order to be able to monitor parameters such as temperature, pH, oxygen concentration and the like, at least one of the capsules in the production unit is advantageously fitted with one or more sensors. Preferably such sensors are optical sensors.
  • In some embodiments the bioreactor factory device also comprises a down stream processing unit placed inside the column. The down stream processing unit comprises at least one down stream processing capsule and at least one pumping capsule. In other embodiments the bioreactor factory device the down stream processing unit is placed outside the column. In yet other embodiments the bioreactor factory device do not comprise a down processing unit since such down stream processing is not necessary for the collection of the chemical compound of interest
  • The production unit and the down stream processing unit may be placed in any order as compared to one another. Hence, in one embodiment the production unit is positioned on top of the down stream processing unit. In this case a pumping capsule must be positioned as the bottom capsule of the down stream processing unit. And in another embodiment of the present invention the down stream processing unit is positioned on top of the production unit, in which case a pumping capsule is positioned as the top capsule of the down stream processing unit. Hence, one pumping capsule is always positioned as the top capsule and another pumping capsule is always positioned as the bottom capsule in the bioreactor factory device.
  • The down stream processing capsule may perform any separation method which is known in the art. The choice of down stream processing process depends on the chemical compound of interest, which is to be isolated as well as the chemical and physical properties of the media from which the chemical compound is to be removed. In one embodiment, however, the down stream processing capsule is selected from the group consisting of a membrane filtration capsule, a separation capsule, a ion exchange capsule, a purification capsule, a chromatography capsule, an activated carbon capsule, and a packed bed capsule.
  • In a preferred embodiment, however, the down stream processing capsule comprises a flow-through matrix made up of a number of tubes through which the liquid to be processed is flowing. The compound of interest is separated from the liquid due to the action of the tubes, for example by being bound to the wall inside the tube by chemical or physical interaction. In a particular preferred embodiment the capsule is constructed similar to the capsule shown in FIG. 8.
  • Once the capsules are assembled into a stack the capsules may be supplied with means for exchanging liquids and information and the like. Hence, in one embodiment the capsules of the bioreactor is further provided with interlocking interface areas for exchange of fluid, electrical signals, electrical power, pneumatic signal exchange and/or vacuum signal exchange.
  • Once the capsules are assembled into a stack means for keeping the stack together during operation of the bioreactor factory would be advantageously. Consequently, in one embodiment the capsules of the bioreactor are further provided with interlocking means, such as latches, for keeping together the capsules in the stack.
  • It is well known that an important factor when performing microbiological reactions is that bioreactor is sterile at the time of seeding the bioreactor. Hence in order to protect the capsules for being contaminated during assembling a sealing arrangement may be covering the capsules during storage and stacking the capsules and then removed after stacking but before a the capsules in the stack is forced together, preferably by use of the interlocking means.
  • The mode of operation is also flexible. Consequently, in one embodiment the capsules in the stack are placed in the horizontal position next to one another, and in another embodiment the stack of capsules are placed in the upright position vertical to one another.
  • Yet another aspect of the present invention provide a method for cultivating micro organisms and/or producing a chemical compound by use of a biochemical reaction taken place in the bioreactor as described above.
  • Definitions relevant for the present invention:
      • Bioreactor or fermenter—a physical device, a container, a vessel which support biologically active environment and houses micro organism performing a process
      • Bag—a flexible container made from clear plastic foil also used as bioreactor vessel
      • Batch—a bioreactor to which no fresh medium is added and no cultured liquid removed
      • Chemical compound—any compound, which can be formed in bioreactor, and includes, but are not limited to monoclonal antibodies, vaccines, gene therapy, proteins, recombinant proteins, blood derivatives and small molecules, such as anti-cancer drugs as well as enzymes, and food ingredients.
      • Fed-batch—a bioreactor to which fresh medium is added and no cultured liquid removed until end of the process.
      • Perfusion mode operation—operation principle for a Chemostat type of bioreactor, the media are continuously exchanged, fresh nutrients added and product is harvested throughout the culture period
      • Cross flow mode operation—operation principle for a separation, filter unit
      • Micro organism—microbes, cells such as; bacteria, fungi, algae, plankton, enzymes, animal, mammalian, tissue, yeast, plant, insect, protozoa, viruses, prokaryotic, eukaryotes, archaea, stem cells, micro animals, extremophiles.
      • Anchorage dependent—cultivation of micro organism anchored onto a surface
      • Suspension dependent—cultivation of micro organism, cell lines suspended in liquids
      • Growth media, nutrient—fluid containing mostly miter, carbon sources, various gases such as oxygen, vitamins, etc.
      • Membrane—a layer of material, which serves as a selective barrier between two phases and remains impermeable to specific particles, molecules, or substances when exposed to the action of a driving force.
      • Separation—dividing fluid borne particles of different size by membrane filtration into at least two separate fluid streams
      • Filtration—mechanical method to separate solids from liquids or gases by passing the feed stream through a porous sheet such as a membrane, which retains the solids and allows the liquid to pass through.
      • Purification—physical separation of a chemical substance of interest—typically performed downstream of the bioreactor in order to separate the product (like proteins) from waste (used and dead cells, damaged cells)
      • Chromatography—Size Exclusion Chromatography—a device that holds chromatographic packing material, often the final step in a purification process. SEC works by trapping these smaller molecules in the pores of a particle. The larger molecules simply pass by the pores as they are too large to enter the pores.
      • Disposable—products manufactured from organic materials preferably taken from the group consisting of thermo polymers, thermo setting polymers, and elastic polymers
      • Porosity—is a measure of the void spaces in a material expressed in percent 0-100%
      • Macro pore size—ranging 10-500 μm
      • Meso pore size—ranging between 1-10 μm
      • Micro pore size—ranging below 1 μm
      • Non-woven—is a fabric-like flat porous sheets made from fibres, bonded together by chemical, mechanical, heat treatment, such as felt, which are neither woven nor knitted
      • Honeycomb body—a one piece body with a multiple parallel small channel manufactured typically from ceramics
      • Column—a series of capsules stacked on top of each other
      • Capsules—a series of identical shaped containers of equal diameter, but with height according to the content, like one UH unit being 128 mm, two UH units being 256 mm
      • Tri-clamp ports, flange—an industry method of assembling a hose to a container or pump, the Tri-clamp flanges are separated by a seal and kept together by the clamp with internal conical walls.
    BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1—A column assembled from 3 bioreactor capsules and two pumping capsules, one pumping capsule at each end of the bio reactor capsule in opposite position facing the bioreactor.
  • FIG. 2—A pumping capsule with details of the diaphragm and two designs of valves
  • FIG. 3—A bioreactor capsule with ten fibrous matrix discs
  • FIG. 4—A down stream processing capsule with eighteen depth filter discs
  • FIG. 5—A manifold capsule with valves
  • FIG. 6—A conditioning capsule with heating element
  • FIG. 7—A conditioning capsule with cooling or sparging tubular element
  • FIG. 8—A diffusion capsule for various gases or filtration, separation purposes
  • FIG. 9—An extended column comprising two bioreactor capsules, one down stream processing capsule, three pumping capsules, one manifold capsule, and two conditioning capsules
  • FIG. 10—The stack in principle, and principle fluid circuit diagram
  • DETAILED PRESENTATION OF THE INVENTION
  • Capsule Physical Design in General
  • Stacking may be performed by arranging the capsules next to each other in a pivoting holder system and the capsules in the stack may be interconnected by use of fluid exchange flange seals and kept together by use of clamps with such a force that the seals insure liquid tight performance. The numbers of capsules to be stacked are at least three and the stack could be as high as 2 meter.
  • The design of the preferred disposable capsules may be of tangential flow principle, radial flow principle, cross flow principle with symmetric or asymmetric porous bioreactor matrix design and either of round design, rectangular or combinations thereof.
  • The capsules may comprise channels for cooling or heating within the capsule structure, and the capsules may also comprise sanitary flange fittings such as tri-clamp or the common industrial 25 mm port for sensor, electrode connections.
  • The size of the capsules is not limited, but may be such as 12 or 16 inches or as the capsules shown in the figures, which are of 442 mm in diameter. Sizes of the invented capsule designed column could match sizes in the industry like 12 or 16″ being a diameter standard from 3Ms CUNO or Pall STAX product line. Capsules could even be of size like from 100 mm up to 1000 mm in diameter. For a bench-top column diameter of 150 mm and height of 400 mm results in a weight of less than 20 kilo. For a production column designed with 442 mm diameter and 1500 mm height the total weight is less than 100 kilo and the bottom control capsule support the column to a wheel base, which also allows easy transportation within the production facility premises.
  • The capsule concept according to the present invention preferably combines communication along the column, such as wires, hoses, etc for transmission of signals for processing purposes or tasks for actuators to perform. A transmission line integrated in the capsules with plugs, and connectors, which integrate, when capsules are assembled.
  • Very compact and passive manifold capsules with no valves are commercially available with tri-clamp inlet and outlet flanges, which allow fluid connection to any of the capsules of the present invention.
  • Assembling the Capsules into the Stack
  • The bioreactor capsules, or cassettes, of the present invention may be combined in the same commercial filter pivoting holder system with similar sized filtration capsules, or cassettes for cell culture product clarification. The proposed set-up is a very compact solution and will enable the manufacturer to cut production cost and facility size further. FIG. 9 illustrates a 1.7 meter high bio factory system with in total 9 capsules of which two are bioreactor capsules and one is a down stream processing capsule. The single-use, pre-sterilized capsule or cassette concept allows for fast exchange, development, variable capacity and small foot print.
  • Yet another variation of the present invention provides non round capsules or cassettes with at least one fluid inlet and at least one fluid outlet integrated within the capsules design. Such as the Plate & Frame design, an expression for old fashion assembling of a larger number of cassettes into a holder system with the typically square or rectangular plates, which typically operate in parallel. Also known as “filter presses” or “membrane plate filters” in the industry. A very common principle in the filtration industry and the design, column principle may be used for the bioreactor of the present invention.
  • The present invention also relates to the capsule design with interlocking mechanical clamp, means such as latches, which allow two or more individual capsules to be locked together fully independently of the known holding systems. The interlocking mechanical means is preferably based on two or more solid stainless steel rods, one rigid end plate and one movable top plate including a threaded arrangement to tighten the stacked capsules. The present invention eliminates the problems of contaminating the lab or production facility when being disassembled for disposal after use. Disassembling a stack of capsules filled with contaminant should in no way be exposed to the facilities, but rather be directly disposed of.
  • The single-use capsules assembled into larger set-up could be stacked within a horizontal pivoting holder system and the stack is then removed from this tool after assembly. In general the present invention avoids permanent use of stainless steel holding, pivoting systems.
  • Breakable seal in foil may cover the complete capsules end surface. Breakable seal in foil is covering each individual through going, fluid connector, manifold, flange for interconnections and protects the surface of the capsules from the surroundings. The capsules are stacked and the integrity seals are removed by pulling the seal in a radial direction exposing the two fluid connections to each other ready for interfacing. Use of seals on capsules is relevant on both bench-top systems and larger floor mounted systems. Bench-top systems could alternatively be delivered pre-assembled from the supplier.
  • Two capsules end face foil seals facing each other protect a sterilized and gas protected surface, internal devices and connections. The foil is double in a design where the outer foil is equipped with a handle and a 180 degree bend opposite of the handle. When the handle is pulled the sealing foil will slip the circumference attachment. When two capsule seals are removed simultaneously no contamination reaches the fluid connection and gas connection. Also a slight overpressure of protective gas in each capsule insures no contamination is sucked into the capsules.
  • A thin foil seal is integrated and glued on the circumference for protection purposes, and cover the entire end face and all the fluid flanges. Each capsule is to be connected without rotation to the next capsule controlled by a simple pair of male and female tracks located in a non-symmetrical mode on the capsule circumference outside the cover seal, which allow capsules of the column to be assembled without breaking the seals and prohibit incorrect orientation. The foil is to be broken when two capsules are correctly positioned towards each other exposing fluid connection, gas connection, electrical connectors rotational correct oriented towards the neighbouring capsule. The foils are removed simultaneously by dragging both foils of in a double mode configuration without exposing any end face to the local environment. After seal removal the two capsules need to be forced and pushed together for positive connection with latches.
  • For the ultimate very large bio factory system two or more different designed columns preferably work together and are connected internally with hoses via the tri-clamp port system. One column primarily assembled from bioreactor capsules, conditioning enclosed by at least one pumping capsule in each end. The sister column contains a number of desirable down stream processing capsules and two to three pumping capsules. The pump & valve control capsule allow via its communication bus to connect all data transfer with PLC or PC.
  • 1. Bioreactor Capsules
  • In principle the design and the mode of operation of the bioreactor capsule may take any form known within the art. Therefore, as used herein in one embodiment, the term “bioreactor” or “bioreactor capsule” also refers to a packed bed reactor chamber or a reactor which employs flow of biological cell culture and/or feeding liquid medium there through and which may be used for the growth of cell cultures or for packing with suitable support materials or matrices, such as, for example and without limitation, beads in the micrometer or millimetre scale (diameter), micro-spheres in general, micro-carriers, and the like, to which cells or cell colonies or cellular components can be attached or on which individual, isolated enzymes or enzyme systems can be immobilized for reaction with selected substrates.
  • In another embodiment the bioreactor of the present invention may also comprise a continuous, integrated membrane system. In the core of the bioreactor according to this embodiment of the present invention, the cells are confined between two membranes which form a cell chamber, at least one of which is preferably microporous and hydrophilic and permits free passage of nutrients present in a feeding liquid.
  • In one preferred embodiment the bioreactor capsules may comprise a plurality of permeable discs. The permeable disc of the present invention preferably does not contain or comprise a monolith, such as a ceramic thin wall, multi channel, and parallel channel monolith. Also, the permeable disc of the present invention preferably does not contain or comprise microspheres, such as e.g. essentially spherical beads.
  • The discs according to the present invention can be of any form and shape. In one embodiment the discs are circular with an optionally cut-out central portion to allow for the adaptation of a feeding tube or a collection reservoir in operable contact with the discs. The height (i.e. thickness) of the discs is preferably less than 500 millimeters, such as preferably less than 400 millimeters, for example preferably less than 350 millimeters, such as preferably less than 300 millimeters, for example preferably less than 250 millimeters, such as preferably less than 200 millimeters, for example preferably less than 150 millimeters, and preferably more than 1 millimeter, such as more than 2 millimeters, for example more than 5 millimeters, such as preferably more than 8 millimeters, for example preferably more than 10 millimeters, such as preferably more than 12 millimeters, for example preferably more than 14 millimeters, such as preferably more than 16 millimeters, for example preferably more than 18 millimeters, such as preferably more than 20 millimeters, for example preferably more than 22 millimeters, such as preferably more than 24 millimeters, for example preferably more than 26 millimeters, such as preferably more than 28 millimeters, for example preferably more than 30 millimeters, such as preferably more than 40 millimeters, for example preferably more than 50 millimeters.
  • The diameter of the discs (including the optionally cut-out, central portion) will depend on the reactor design, including the height of the discs, and the disc diameter is, in one embodiment, preferably less than 500 centimeters, such as less than 480 centimeters, for example less than 460 centimeters, such as less than 440 centimeters, for example less than 420 centimeters, such as less than 400 centimeters, for example less than 380 centimeters, such as less than 360 centimeters, for example less than 340 centimeters, such as less than 320 centimeters, for example less than 300 centimeters, such as less than 280 centimeters, for example less than 260 centimeters, such as less than 240 centimeters, for example less than 220 centimeters, such as less than 200 centimeters, for example less than 190 centimeters, such as less than 180 centimeters, for example less than 170 centimeters, such as less than 160 centimeters, for example less than 150 centimeters, such as less than 140 centimeters, for example less than 130 centimeters, such as less than 120 centimeters, for example less than 110 centimeters, such as less than 100 centimeters, for example less than 90 centimeters, such as less than 85 centimeters, for example less than 80 centimeters, such as less than 75 centimeters, for example less than 70 centimeters, such as less than 65centimeters, for example less than 60 centimeters, such as less than 55 centimeters, for example less than 50 centimeters, such as less than 45 centimeters, for example less than 40 centimeters, such as less than 35 centimeters, for example less than 30 centimeters, such as less than 25 centimeters, for example less than 20 centimeters, and preferably more than 1 centimeter, such as more than 2 centimeters, for example more than 3 centimeters, such as more than 4 centimeters, for example more than 5 centimeters, such as more than 6 centimeters, for example more than 7 centimeters, such as more than 8 centimeters, for example more than 9 centimeters, such as more than 10 centimeters, for example more than 12 centimeters, such as more than 14 centimeters, for example more than 16 centimeters, such as more than 18 centimeters.
  • The permeable disc fibres preferably has, in one embodiment, an average diameter in the range of from 0.01 micrometer to preferably less than 100 micrometers, such as an average fibre diameter of from 0.05 to preferably less than 100 micrometers, for example an average fibre diameter of from 0.10 to preferably less than 100 micrometers, such as an average fibre diameter of from 0.15 to preferably less than 100 micrometers, for example an average fibre diameter of from 0.20 to preferably less than 100 micrometers, such as an average fibre diameter of from 0.25 to preferably less than 100 micrometers, for example an average fibre diameter of from 0.50 to preferably less than 100 micrometers, such as an average fibre diameter of from 1.0 to preferably less than 100 micrometers, for example an average fibre diameter of from 2.0 to preferably less than 100 micrometers, such as an average fibre diameter of from 4.0 to preferably less than 100 micrometers, for example an average fibre diameter of from 6.0 to preferably less than 100 micrometers, such as an average fibre diameter of from 8.0 to preferably less than 100 micrometers, for example an average fibre diameter of from 10 to preferably less than 100 micrometers, such as an average fibre diameter of from 12 to preferably less than 100 micrometers, for example an average fibre diameter of from 14 to preferably less than 100 micrometers, such as an average fibre diameter of from 20 to preferably less than 100 micrometers, for example an average fibre diameter of from 25 to preferably less than 100 micrometers.
  • The packing density of the permeable disc fibres is preferably, in one embodiment, in the range of from 100 to 5000 gram/meter2, such as from 100 to 200 gram/meter2, for example from 200 to 300 gram/meter2, such as from 300 to 400 gram/meter2, for example from 400 to 500 gram/meter2, such as from 500 to 600 gram/meter2, for example from 600 to 700 gram/meter2, such as from 700 to 800 gram/meter2, for example from 800 to 900 gram/meter2, such as from 900 to 1000 gram/meter2, for example from 1000 to 1100 gram/meter2, such as from 1100 to 1200 gram/meter2, for example from 1200 to 1300 gram/meter2, such as from 1400 to 1500 gram/meter2, for example from 1500 to 1600 gram/meter2, such as from 1700 to 1800 gram/meter2, for example from 1800 to 1900 gram/meter2, such as from 1900 to 2000 gram/meter2, for example from 2000 to 2100 gram/meter2, such as from 2100 to 2200 gram/meter2, for example from 2200 to 2300 gram/meter2, such as from 2300 to 2400 gram/meter2, for example from 2400 to 2500 gram/meter2, such as from 2500 to 2600 gram/meter2, for example from 2600 to 2700 gram/meter2, such as from 2700 to 2800 gram/meter2, for example from 2800 to 2900 gram/meter2, such as from 2900 to 3000 gram/meter2, for example from 3000 to 3100 gram/meter2, such as from 3100 to 3200 gram/meter2, for example from 3200 to 3300 gram/meter2, such as from 3300 to 3400 gram/meter2, for example from 3400 to 3500 gram/meter2, such as from3500 to 3600 gram/meter2, for example from 3600 to 3700 gram/meter2, such as from 3700 to 3800 gram/meter2, for example from 3800 to 3900 gram/meter2, such as from 3900 to 4000 gram/meter2, for example from 4000 to 4100 gram/meter2, such as from 4100 to 4200 gram/meter2, for example from 4200 to 4300 gram/meter2, such as from 4300 to 4400 gram/meter2, for example from 4400 to 4500 gram/meter2, such as from 4500 to 4600 gram/meter2, for example from 4600 to 4700 gram/meter2, such as from 4700 to 4800 gram/meter2, for example from 4800 to 4900 gram/meter2, such as from 4900 to 5000 gram/meter2, including any contiguous combination of the afore-mentioned sub-intervals.
  • Preferably, the volume of the open cells/pores of the matrix of the permeable discs/stacks is preferably less than 95% of the volume of the disc/stack itself, such as preferably less than 90%, for example less than 85%, such as less than 80%, for example less than 75%, such as less than 70%, for example less than 65%, such as less than 60%, for example less than 55%, such as less than 50%, for example less than 45%, such as less than 40%, for example less than 35%, such as less than 30%, for example less than 25%, such as less than 20%, and preferably more than 5%, for example more than 10%, such as more than 15% of the volume of the disc/stack itself.
  • The number of permeable discs/stacks present in the bio-reactor, or a capsule thereof, can be any number, preferably a number of from 2 to 100, such as 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 and 100. The number of permeable discs/stacks is preferably an even number.
  • The bioreactor of the present invention may according to one embodiment comprise a porous matrix, one or more bio-reactor inlet port(s) and one or more bio-reactor outlet port(s),
  • wherein said matrix is suitable for anchoring and/or supporting the cultivation of living cells or micro organism in general,
  • wherein said matrix separates said one or more bio-reactor inlet port(s) from said one or more bio-reactor outlet port(s),
  • wherein said matrix comprises individual matrix sections each separated by a spacer section for diverting feeding liquid to or from said individual matrix sections.
  • Each of such “individual matrix section” can comprise a plurality, as for example at least 2, “individual matrix sub-sections”, wherein each such sub-section is separated from another sub-section by a permeable layer comprising a plurality of openings exerting a biological cell retaining function, but not a feeding liquid retaining function, wherein the diameter of the openings of the permeable layer is smaller than the diameter of the biological cells to be cultivated, thereby creating a layer in between individual matrix sub-sections which is capable of diverting feeding liquid in a direction essentially perpendicular to the direction in which feeding spacers and drainage spacers are diverting feeding liquid to and from, respectively, the individual matrix sections.
  • The thickness of an individual “permeable layer”, or the collective thickness of a plurality of “permeable layers” dividing an individual matrix section into a plurality of sub-sections, is preferably less than 10% of the thickness of the individual matrix section comprising said one or more permeable layer(s). The one or more permeable layer(s) preferably divide an individual matrix section into sub-sections having at least essentially similar thicknesses, i.e. no sub-section differs in thickness by more than 10% from any other individual matrix sub-section.
  • The permeable layer(s), when present, ensures that feeding liquid can flow from a feeding liquid spacer either through the individual matrix sections, or through the permeable layer, thereby further reducing and/or eliminating gradients of feeding liquid nutrients in the bio-reactor. Without being bound by theory, it is believed that the flow rate of feeding liquid along the permeable layer will be faster than the flow rate of feeding liquid through the individual matrix parts. However, it is also possible that under some practical conditions of bio-reactor operation, the flow along flow rate of feeding liquid along the permeable layer will be slower than the flow rate of feeding liquid through the individual matrix parts. Under such practical circumstances the feeding liquid being diverted along the permeable layer can be regarded as a supplemental source of feeding liquid useful for obtaining and sustaining optimal biological growth conditions.
  • In one aspect of the present invention there is provided a bio-reactor comprising a plurality of permeable discs comprising a matrix comprising a plurality of fibres defining a plurality of inter-connected, open cells or pores extending through at least part and preferably all of each disc,
  • wherein biological cells are capable of adhering to the fibres and capable of residing in at least some and preferably all of the inter-connected, open cells,
  • wherein the plurality of permeable discs are alternately separated by feeding spacer sections and drainage spacer sections, respectively, so that each feeding spacer section provides feeding liquid to each of a first set of two adjacently located, permeable discs and so that each drainage spacer section receives feeding fluid from each of a second set of two, adjacently located, permeable discs,
  • wherein each disc is contacted by one feeding spacer section and one drainage spacer section, respectively, on opposite sides of the disc,
  • wherein essentially all feeding liquid entering the disc from the side of the disc on which the feeding spacer section is located is diverted through the disc and exits the disc on the opposite side of the disc, where the drainage spacer section is located.
  • The first set of two adjacently located, permeable discs and the second set of two adjacently located, permeable discs have one disc in common when the feeding spacer section and the drainage spacer section are positioned next to each other in the bio-reactor, i.e. when they contact opposite surfaces of one and the same disc.
  • The overall flow of a feeding liquid through each disc is essentially in a direction which is perpendicular to the direction of the flow of feeding liquid along the feeding spacer section feeding said disc, i.e. the matrix material of the disc exerts a “cross-flow” effect on the feeding liquid. Likewise, once feeding liquid exits a disc it is diverted along the drainage spacer section in a direction which is also essentially perpendicular to the direction of flow of feeding liquid through the disc.
  • The open cells or pores of the matrix of the permeable discs are larger in diameter than the biological cells to be cultivated, thereby allowing said cells to reside in said open cells during all or part of the duration of the fermentation.
  • The bio-reactor can be fitted with a suitable pump in order to ensure the a desirable flow rate is obtained. The bio-reactor can also be fitted with sensors and a control unit for controlling the seeding of cells and the progression of the subsequent fermentation.
  • In another aspect of the present invention there is provided a bio-reactor comprising a plurality of permeable discs or stacks comprising a matrix comprising a plurality of fibres defining a plurality of inter-connected, open cells or pores extending through at least part and preferably all of each disc,
  • wherein biological cells are capable of adhering to the fibres and capable of residing in at least some and preferably all of the inter-connected, open cells,
  • wherein the plurality of permeable discs are alternately separated by feeding spacer sections and drainage spacer sections, respectively, so that each feeding spacer section provides feeding liquid to each of two adjacently located, permeable discs and so that each drainage spacer section receives feeding fluid from each of two, adjacently located, permeable discs,
  • i) a plurality of permeable discs comprising a matrix comprising a plurality of fibres defining a plurality of inter-connected, open cells or pores extending through at least part and preferably all of the disc,
  • wherein biological cells are capable of adhering to the fibres and capable of residing in at least some of the inter-connected, open cells,
  • wherein the plurality of permeable discs are alternately separated by feeding spacer sections and drainage spacer sections, respectively, so that each feeding spacer section provides feeding liquid to each of two adjacently located, permeable discs and so that each drainage spacer section receives feeding fluid from each of two, adjacently located, permeable discs,
  • ii) one or more inlet ports for diverting a feeding liquid to one or more feeding tubes of the reactor,
  • iii) one or more axially elongated feeding tubes comprising a plurality of openings through which feeding liquid can be diverted to each of the plurality of permeable discs,
  • iv) a plurality of elongated and optionally cross-linked feeding spacers in liquid connection at a proximal end thereof with the one or more feeding tubes and extending in an essentially radial direction therefrom,
  • wherein feeding liquid can be diverted from said one or more feeding tubes to said plurality of feeding spacers through said holes of said one or more feeding tubes,
  • wherein the distal end of each feeding spacer is not connected to an outlet port for diverting feeding liquid to a collection reservoir,
  • wherein each feeding spacer separates two adjacently positioned permeable discs,
  • v) a plurality of elongated and optionally cross-linked drainage spacers in liquid connection at a distal end thereof with one or more outlet ports for diverting feeding liquid to a collection reservoir,
  • wherein the plurality of drainage spacers are located essentially in parallel to the plurality of feeding spacers,
  • wherein feeding liquid can be diverted from each of said plurality of feeding spacers and through a pair of neighbouring, permeable discs separated by a feeding spacer to one or more drainage spacers,
  • wherein the distal end of each drainage spacer is not connected to a feeding tube hole,
  • wherein each but end-positioned drainage spacer(s) separates two adjacently positioned permeable discs,
  • vi) a wall section comprising a plurality of collection reservoir outlet ports,
  • wherein each collection reservoir outlet port is in liquid contact with a collection reservoir, and
  • vii) a collection reservoir for collecting feeding liquid diverted to said collection reservoir from the permeable discs via drainage spacers and through said collection reservoir outlet ports.
  • 2. Temperature Conditioning Capsules
  • A number of different designs of heat exchangers for cooling or heating, which are commercial available for temperature regulations, may be used and incorporated into the bioreactor stack of the present invention in order to control the temperature of the liquid flowing through the bioreactor.
  • The fermentation or micro organism activity is typically an exothermic process generating heat. The volume/surface ratio of the reactor is decisive for weather heat must be applied or removed. For insect cells the required process temperature lies in the range of 27-28 degree Celsius and for mammalian cells the needed temperature is around 37 degree Celsius. Media contact either by flat surface or tube contact in a capsule with external connections for internal sterility and less demand to external conditions. The fluid from an external temperature conditioning devise is constantly circulated in the fluid-conditioning capsule controlling the stack temperature. More than one temperature conditioning capsule may be suited for a high stack.
  • Temperature regulation could also be done with integrated Peltier elements, which are able to either cool or heat depending on how the DC poles are connected to the two element connections.
  • Heating is performed preferably by the heating element cast located in suitable plastics. Flat cupper bands located between two connection points and oriented In a spiral forms the resistant heating element Alternatively, the product Bekinox, which is available from the Belgium company Bekaert, could also be incorporated in the conditioning capsule.
  • 3. Gas Conditioning Capsules
  • Unlike bacterial cultures, which are aerated with air, cell cultures are aerated with multiple gases such as oxygen, nitrogen, CO2, and air in a mixture, which is specific for each type of micro organism and the specific fermentation process. Gas composition is regulated by sensitive control systems, and an optimum gas atmosphere should be formed and maintained for the fermentation and manufacture of the product. During cell proliferation the pH of the medium changes and keeping pH constant is vital for many production processes and therefore it must be controlled. pH control could be done by adding acids and bases as it is done in bacterial fermentations but preferably addition of CO2 is controlling the pH.
  • The supply gases are usually accomplished from an external mounted gas-mixing station. In the invented device the dosage of each gas is controlled by the comprehensive control capacity included in the pump & valve controller. As the gas mixing takes place within the diffusion capsule, the delay time from long hoses from an external mounted gas mixing station is eliminated. The pump & valve controller regulates pH by adding dosages of CO2 and the O2 control regulates the aeration with air or Oxygen and Nitrogen. Thus the optimum gas supply for the micro organisms is facilitated for every phase of the fermentation.
  • Two principles are well known for adjustment of the oxygen concentration in the circulated media:
      • Diffusion capsule—capable of exchanging O2 and CO2 through a membrane which is permeable to gas and impermeable to liquids. Such membranes have fluid on one side of the membrane and pressurized sterilized gas on the other side. Gas transfer occurs by diffusion in either direction. FIG. 8 illustrate such invented capsule.
      • Sparging air capsule—with sterilized air or O2 by pressure forced through a micro porous diffuser membrane by applying a pressure and thereby creating micro bubbles ranging in size from nano meters to 2,000 μm in size. Separate pressure sensors connected to a gas chamber insure positive overpressure, which avoid fluids passing from pumping chamber into the gas chamber through the porous wall. In one aspect the sparging of gas into a fluid is supported by ultra sound, vibration devices helping break up bubbles. Both FIGS. 7 and 8 illustrates such invented capsule.
  • The amount of dissolved Oxygen (dO) is limited by the low solubility of oxygen in aquatic buffers and media. In general cells demand 10-14 to 10-13 mole oxygen per cell per hour and therefore efficient oxygen transfer for high dell density fermentations is critical. Although sparging with air/oxygen bubbles can efficiently transfer oxygen to the medium, such bubbles can cause severe damage to the cells. Cultivated mammalian cells are damaged by air-liquid interfaces due to the interaction with gas bubbles. Therefore a bubble free diffusion capsule with gas transfer by diffusion is most efficient. Other micro organisms are much more tolerant to bubbles. The diffusion materials are typically:
      • Hollow fibre membranes, which are well recognised for the filtration performance. Hollow fibre membranes are typically of hydrophobic character with membrane pores ranging from 1-500 nm in diameter, typically 10-100 nm. The fibres may have outside diameter ranging from 1-10 mm. The membranes are bundled, stacked between two epoxy end covers typically cast further into a rigid plastic tube integrating the porous device.
      • Gas-permeable hoses/tubeffibre capsule such as hollow micro pore, porous tubes like manufactured from silicone rubber, PFTE.
  • Examples of sparging materials are:
      • Porous products, tubes made from glass and plastics often based on particles linked, fused together into the porous structure often have pore size ranging from 10 μm and up.
      • Porous products, tubes made from ceramics offer a wide variety of pore sizes ranging from nano meters and up.
      • Porous plastic membranes range from nano size pores and up.
  • The media supply capsule receives new nutrient, and optionally various gases preferably in concentrated form and is supplied dilute into the re-circulating fluid according to the information send from sensors on a real-time basis and prediction all controlled by the PLC within the pump & valve controller.
  • The pH and O2 adjustment may take place in separate individual capsules or both adjustments may take place in the same capsule. Supply of fresh nutrient liquid may take place in any of the capsules in the biofactory or the supply may occur in a separate capsule.
  • 4. Down-Stream Processing Capsules, Such as Depth Separation, Surface Separation, Ion Exchange or other Purification Devices
  • Any down stream processing method and design known in the art may be incorporated into the bioreactor of the present invention. In this step the product of interest is isolated from the liquid leaving the production unit.
  • Hence, the first step after the bioreactor (production unit) of the retentate flow is the down stream processing or pre-clarification or product clarification. Many desirable principles are well-known without being necessary practical to utilize. FIG. 8 illustrate such a situation as the invented multi-channel containing capsule combined with pumping capsule (FIG. 2) and manifold capsule (FIG. 5) facilitates operation after the Tangential Flow Filtration (TFF), also known as Cross Flow Filtration (CFF) principles. Which is a rapid and efficient method for filtration and separation of solutions containing bio molecules, or particles such as viruses, bacteria or cellular material.
  • In a first process the product flow (such as feed after bioreactor) is directed tangentially along the surface of a hollow fibre membrane with most of the solution circulated back to the feed storage as retentate. The high velocity cross flow creates a pressure drop, which forces some of the feed solution and dissolved molecules that are smaller than the pores in the membrane, through the membrane filter. The solution that passes through the membrane is referred to as filtrate or permeate. Molecules or particles larger than the membrane pores are retained in the feed solution and effectively concentrated. The fluid dynamics of cross flow filtration reduces membrane fouling and maintains filtration rates (flux) for a longer period of use, thus increasing membrane throughput (greater capacity) compared to traditional cartridge (direct flow) filtration.
  • In a second cleaning process step the high velocity feed solution along the membrane surface acts to ‘sweep’ the surface, reducing concentration polarization (product concentration at the membrane surface). It also prevents build-up of foulants that can plug the pores at the membrane surface.
  • In an additional third cleaning process the membrane module is exposed to a fluid pulse in the opposite direction, a back-flushing pulse, which helps remove potential build up on the feed flow side of the membrane. All such methods are well known within the filtration industry.
  • Also the option of sterilization with 200 nm filters or better are available on the marked from many vendors, such as the Fluorodyne® EX Filter Series from US company Pall. The new products from CUNO, the Zeta Plus™ EXT line of depth filters are supplied with two types of media that perform complementary purifications during post-cell culture harvest. Composed of cellulose and a positively charged resin, EXT SP is an open-grade medium that serves as an upstream or pre-filter that can replace centrifugation for small (<200 L) batches. EXT ZA media are of tighter grade and hold a strongly positive resin for removal of host cell proteins and DNA. Down stream processing capsules may easily be incorporated into the invented column present in the bioreactor and single-use pumps may also be present.
  • Centrifuging is less of a required process as the producing micro organism is kept stationary, contained in bioreactor capsule. Down stream the bioreactor a depth filter may efficiently trap, capture the low levels of cell debris, impurities in the harvest stream. Modem depth filters can be effectively employed in an adsorptive capacity for the capture of soluble impurities in addition to their conventional use in clarifying particle moderate fluid streams. The present invention is designed to replace energy-consuming centrifuges in a biotech process. Centrifuges are after all not single use, difficult to scale up and require a high effort for cleaning, cleaning validation and maintenance.
  • One of several final steps in down stream processing is the popular chromatography method for product contaminant removal and capture of large target molecules.
  • At least three methods are known:
      • 1. Liquid chromatography ion-exchange to separate proteins take advantage of the fact that the molecules is suspended in a solution (mobile phase) and will interact with the chromatography media (stationary phase).
      • 2. Packed bed ion-exchange chromatography with capsules for stacking options are well-known and are typically based on a solid absorbent resin (functionalised porous beads or gel polymer) such as the hydrophilic dextran, but zeolites, montmorillonite and diatomaceous earth have also been used. According to the difference of the interaction forces between the protein and adsorbent, different protein is bound differently by the adsorbent. When other buffers are used to replace the protein, the proteins will be eluted at different velocity: the less the interaction between the adsorbent and the proteins, the sooner they will be eluted. Then, proteins can be separated according to the sequence of their elution. Ion exchangers are either cation exchangers that exchange positively charged ions (cations) or anion exchangers that exchange negatively charged ions (anions). There are also amphoteric exchangers that are able to exchange both cations and anions simultaneously. However, the simultaneous exchange of cations and anions can be more efficiently performed in mixed beds that contain a mixture of anion and cation exchange resins, or passing the treated solution through several different ion exchange materials.
      • 3. Membrane chromatography ion-exchange is well within the reach of becoming disposable and hereby possible to introduce into the invented column. In membrane chromatography processes, the transport of solutes to their binding sites take place predominantly by convection and the pore diffusion is very small as compared to the packed bed column, and thereby the mass transfer resistance is tremendously reduced. The binding capacity of membrane adsorbents for large size protein is much higher than that of traditional beads in packed beds. Membrane chromatography has higher capture efficiency and higher productivity than column chromatography and shows the most promising industrial applications for the recovery, isolation and purification of proteins and enzymes.
  • Several companies offer perfusion chromatography media to be included in capsules of and integrated in the present invention for the small foot-print, which is one of the key elements of the invention. Some chromatography media is even suitable to apply on micro porous membranes as coatings combining several features into one device.
  • Chromatography separation, which relies on membrane separation, depends partly on pressure drop, as to the extremely small pore size, somewhat higher, ranging pressures of 100-300 kPa. This technique and method is well within the reach of being of disposable character and hereby possible to introduce into the invented column.
  • Another final purification step of increased interest is separation by suspension crystallization based on freezing with refrigerants equipment temperature capacity ranging to minus 60 degree Celsius. The crystalliser converts the feed into a slurry of pure product crystals and the residual mother liquor. Typically the cooling takes place in one column being a part of a loop where the crystal growth and separation takes place in a separate column before traditional mechanical device compresses the slurry to remove the mother liquor and form a packed crystal bed. This bed consists of the pure product crystals surrounded by some residual mother liquor. The equipment for this process is large, depends on materials, which eliminate that the technology becomes easily of disposable character. Companies like GEA, Sulzer and other offer such equipment.
  • Another final purification step includes high frequency resonant ultrasonic waves to separate cells instead of a physical mesh or membrane, which offers all the benefits of traditional devices but without their inherent problems and limitations. Technology based on acoustic resonance, is a non fouling/non clogging retention system offered by company Applikon from The Netherlands. A technique well within the reach of being disposable and hereby possible to introduce into the invented column.
  • 5. Pumping Capsules
  • The present invention comprises a capsule integrated reciprocating diaphragm pump based on single-use materials, single diaphragm pumping device, operating from absolute pressure to over atmospheric pressure, in its most simple form with electronically control by micro processor connected to various sensors and pneumatics operated valves, which are also present in the fluid streams. A preferred design of a pumping capsule is shown in FIG. 2.
  • Mostly the invented column set-up will require at least one capsule pump operating against either other pumps or flexible volume to compensate for pump pulses and volume change, such as:
      • 1. One or more similar capsule pumps integrated in the column.
      • 2. External bio container(s)
      • 3. Internal storage volume, passive flexible element
  • In the present example the pumping capsule contains the electronics and pneumatics for pump and valve control. The capsules PCB may include provisions for internal data acquisition along the control power supply, which are all based on micro processors. The column capsules may integrate single-use sensors, wiring, and connectors in order to transmit data with the PCB. The column performance and integrity benefit from extended data acquisition capabilities from external mounted sensors of various specification and use.
  • The control unit capsule may further have provisions for control of stand-alone pumps, valves or other devices outside of the column or mounted on one or more of the flanges found on the capsule circumference. Such as valves for the supply of gases to the oxygen condition capsule for Oxygen concentration and pH control. Or such as the control of expandable tube valves in manifold capsules seen at FIG. 5. The pumping capsule or the manifold capsule may have provisions in order to remove entrapped gasses like air from the column start-up. The requirement of pressure relief valve is less of a problem as the fluid pressures are monitored on a real-time base at various location in the capsules, column.
  • Manifold capsules serve several purposes such as with active valves as seen in FIG. 5 comprising four identical valves of which two are in contact with the inner centre tube and the two other valves with the fluid ring tube around the centre. The expandable tube valves are inserted in the capsule body and integrated with flanges outside at the circumference. Valves shown here are pneumatic driven and needs to communicate with the pump & valve control capsule devices intended for such application.
  • The manifold capsule allows alternative drainage or feed, and access to fluids from the two centre fluid passages, which are not accessible by the pumping capsule.
  • 6. Sensors Incorporated in Capsule
  • On-line and real-time measuring of O2, pH, temp, CO2, glucose, flow, pressures, cell counting sensors, etc. for monitoring and process control is mandatory for optimum production in the bioreactor. Any of the embodiments of the present invention may include passageways incorporated for correspondence with traditional electrochemical 12 mm diameter sensors probes for monitoring. Sensors as supplied from Hamilton, Mettler-Toledo, and others with Pg 13.5 thread are used in the industry and inserted in ports via sealed connections.
  • Even though it is preferred to use single-use sensors and due to the fact that the industry shift to disposable bioreactors bags the need for disposable sensors also becomes important and a significant improvement. The above described bioreactor may be placed in a bag of flexible materials or in cassettes, capsules or the like from non flexible materials, which allow the bioreactor to be single-use and disposable. It is advantageous to avoid introduction of any foreign articles such as standard electrochemical 12 mm diameter sensors probes, transmitters after bioreactor sterilization. Such sensors will not accept the sterilization or they loose their calibration. Relevant real-time sensors are such as for those measurements of gases, dissolved gases, liquids, temperature, cell density, organics, pressures, etc.
  • The present invention benefits from disposable sensors which may be integrated into the bioreactor bag or capsule. Optical sensors have the advantages that they can be engineered to be non-invasive or introduced into the bioreactor before gamma sterilization occurs, do not have stringent grounding requirements, and can often provide enhanced perkimance over existing chemical or electrochemical methods. A variety of sensors principles are used; chemical-optical, optical, fluorescence, near infrared spectroscopic—NIR, Partial Least Squares—PLS, Principal Component Analysis—PCS, radio frequency impedance.
  • Compact single-use sensors are manufactured by the German company PreSens Precision Sensing GmbH being flat to less than 1-5 mm, less than 50 mm in diameter with wires or electrical connectors extending from the sensor. Or the sensor elements are attached to the inside of bioreactor corresponding through the translucent container material to a transmitter on the outside for non-invasive and non-destructive operation. An alternative product is manufactured by Finesse Corp from USA who offers a line of disposable optical sensors for detection of dissolved oxygen and pH.
  • Operation Mode
  • Opposite of the common standard batch fermentation the present invention by far takes advantages of continued fermentation.
  • In fed-batch mode, media and other nutrients are added at fixed intervals to the culture, and the product is only harvested at the end of the run. Batch fermentation reactor size vary from bench-top to 25 m3 tanks, operate for 7-90 days and collection of cells or harvest takes place only once per fermenter cycle. Foaming as to the mixer operation in traditional batch operation with a head space is a problem particularly if oxygen take-up is done through the fluid surface in the reactor. In general the cell density is low and CIP, “Cleaning In Place” after operation is highly costly and documentation heavy. This methodology is the most prevalent in the industry today; it is well understood and described, and produces higher yields than batch modes that do not involve feeds. Fed-batch systems are generally reliable; nutrients can be monitored and controlled, and media is used efficiently. As there is only one harvest, this leads to efficient process characterization, harvest of raw materials, and downstream processing. There are some potential disadvantages to the fed-batch method. Waste products such as lactate and NH4+accumulate and the culture degenerates during the run. This can lead to the production of proteases and other degradation enzymes, which can act on the desired product. Also, key nutrients may become exhausted. Since the conditions within the culture may be constantly changing, cells go through several phases of growth, peaks, and troughs of production, and product may be degraded prior to harvest.
  • In perfusion mode, media and other nutrients are continuously exchanged and product is harvested throughout the culture period. Perfusion mode operation allow for continued fermentation and constant harvest. The bioreactor is operated in a configuration basically with one inlet and one outlet. The majority of the fluid flow volume is constantly passing the bioreactor capsule and re-circulated. A minor flow is continuously drained including the product and processed separately and outside of the bioreactor. A similar volume is added as fresh nutrient including oxygen addition. As no head space is required and the oxygenation is done outside the reactor foaming is not a problem. Thus, the process operates as a chemostat with cell retention, where the constant addition of fresh medium and the elimination of waste products provide the cells with the stable environment they require. This enables much higher cell densities to be achieved and, in turn, leads to higher productivity. Recent development results mentioned October 2007 in the magazine Genetic Engineering & Biotechnology News have shown that the ATF allows for relatively high cell densities. Cell numbers up to 7×10*7-x10*8 cells/mL with viability >90% are achieved on a regular basis with CHO cell lines, with perfusion flow limited to less than two volumes per day.
  • Additional Capsules
  • Prior text in the present description is concerned with specific capsule integrated devices. Other devices than those described may be integrated into the capsules for other specific purposes. Devices performing such as or including:
      • Chromatography purification, affinity, ion exchange with membranes.
      • Chromatography purification, ion exchange by packed beads. If capsules are filled with beads, gels, etc such capsules could also be of re-usable character and re-filled after use for circulation to the next production.
      • Cross-flow, micro-filtration, ultra-filtration, membrane purification
      • Bio catalysis reaction typically based on enzymes, to perform chemical transformations on organic compounds.
      • Activated carbon based devices as to the high absorptive capacity suitable to treat fluid for removing colour, odour, etc.
      • UVC irradiation, a short wave, germicidal wavelength that acts by causing dimerization and nicks in the DNA. The 254 nm wavelength is effective at inactivating viruses without damaging the proteins of interest.
      • Ultrasonic wave separation support devices
        In general all the invented capsules are pre-sterilized, of single-use character, which allow aseptic inter-connection in order to avoid cross contamination.
  • Items of the Present Invention
  • The following section discloses aspects and embodiments of the present invention present in the form of items as cited herein below.
  • 1. A bioreactor factory device comprising similar diameter and individual height capsules stacked into a column, said capsules being of different purposes such as:
  • pumping capsules, bioreactor capsules, pre-separation capsules, filtration capsules, storage capsules, conditioning capsules, sparging capsules, diffusion capsules, manifold capsules, column end capsules able to be stacked individually in any order and any number with the proviso that the top capsule and the bottom capsule in the column must be pumping capsules.
  • 2. A bioreactor factory capsule with fluid, electrical, pneumatic connections to neighbouring capsules encapsulating either a; pump, and/or a bioreactor and/or a filtration device, or an electronically control device for the above.
  • 3. A bioreactor factory device of cylindrical capsules comprising interlocking interface areas on each end face of said cylindrical capsule for fluid, electrical signal, electrical power, pneumatics, vacuum signal exchange.
  • 4. A bioreactor factory device comprising similar diameter and individual height capsules stacked into a column comprising interlocking mechanism locking each capsule fluid tight and mechanical stable to each of its neighbour capsules.
  • 5. A bioreactor factory capsule sealing arrangement on each side of the capsules insuring sterile handling to be pulled of when interconnecting the capsules into a stack of at least two capsules.
  • 6. A column of bioreactor factory capsules, according to any of the previous items, stacked, interlocked with and kept in a holding system comprising at least two stainless steel bars in parallel with the centre axis of the capsules for floor use.
  • 7. A column of bioreactor factory capsules, according to any of the previous items, stacked and interlocked with a holding system comprising at least two stainless steel bars in parallel with the centre axis of the capsules for bench top use.
  • 8. Devices according to any one of the previous items, wherein the device or parts of the devices are based on:
      • a) Synthetic polymers in general, such as; resins, polycarbonate, polypropylene, polyethylene, polyethersulfone, polyester, polyoxyethylene, polyacrylonitrile, Polysulfone, ethylene vinyl acetate, cellulose acetate, polytetrafluoroethylene, Polychlorotrifluoroethylene, Polyfluroethylenepropylene, polyvinylidene fluoride, polyvinylidene chloride, Polyamides, acetal, acrylics and further thermoplastics in general
      • b) Synthetic elastomers in general, such as silicone, EPDM, Viton, neoprene, polyurethane
      • c) Natural polymers (also bio polymers) in general, any form of fibres or particles, such as rubber, cellulose, paper, cotton, wool, flax, hemp, coconut, jute, viscose rayon
      • d) Synthetic bio degradable polyester (bio plastics) in general, like; aliphatic polyester such as polylactic acid polymers and polyhydroxyalkanoates families, polybutylene succinate, etc
      • e) Ceramics based on powders, grains and/or fibres, such as non-oxides and/or oxides and/or nitrides based on, SiC, Titanium, Aluminium, Silicon, Zirconium and their combinations
      • f) Synthetic carbon fibre based substances and further carbon and carbon based structures in general
      • g) Metal powders and/or metal fibres and their combinations
      • h) Solid metals such as wires, blanks, balls, spheres, rods, bars, machined parts
      • i) Glass, glass fibres and their combinations or any combination hereof.
  • 9. A method for industrial micro organism cultivation according to any of the previous items using a bioreactor device having a liquid inlet side surface and an opposite liquid outlet side surface. Nutrient flow being prepared externally by adding Glucose, amino acids or the like to the re-circulating fluid, which furthermore contain oxygen introduced via diffusion of oxygen.or air from externally mounted membrane based devices for a nutrient solution suitable for feeding the bio micro organism.
  • 10. A method for industrial bio layer, bio film and/or micro organism cultivation according to any of the previous items operating the present bioreactor device in a perfusion system configuration with two inlet and two outlets. The combined inlet volumes:
      • fresh nutrient supply
      • re-circulated fluid from the pump and the oxygen supply
      • is identical to the volume of combined two fluid outlets:
      • re-circulation fluid across the pump and the oxygen supply
      • product harvesting including loss of used nutrient
  • 11. A method for industrial micro organism cultivation according to any of the previous items using operating the present bioreactor device equipped with one reactor liquid inlet and two separate reactor liquid outlets, performing the cross-flow mode. The reactor inlet flow volume is larger than the reactor permeate flow outlet with at least 10% and the cross retentate, reactor outlet flow is externally re-circulated by a pump to the reactor inlet and kept at selected pressure. The bioreactor product volume, which is included in the permeate volume, is regulated by an external valve or positive displacement pump in order to obtain the desired flow over the bioreactor matrix keeping the fresh nutrient flow gradient below 5% over the matrix.
  • 12. A method according to any of the previous items for industrial biolayer and/or micro organism cultivation and continues product separation operating the bioreactor core containing cassette, capsule devices in a column configuration including and/or mixed with product filtration cassette, capsule devices stacked in any configuration.
  • 13. A bioreactor device according to any of the previous items having disposable sensors, probes integrated.
  • Detailed Description to the Figures
  • FIG. 1 illustrates the capsule assembling principle at its most simple configuration with non visible latches on the circumference frame for inter locking purposes. The configuration is shown in 3D perspective. Each capsule end-face is designed to exchange fluids with the neighbour capsule end-face. It is, however, also possible to exchange gases, electrical supply, data communication and sensor information via wires, hose integrated in the circumference wall. The capsules are of identical diameter (in all the illustration of 442 mm) for simple inter connection and preferably designed in several different heights named UH (one Unit Height in the illustration is 128 mm), such as:
      • Bioreactor capsules (111, 112, 113) each being two .UH
      • Pumping capsules (14 a, 14 b) being one and a half UH
  • Each of the three bioreactor capsules (111, 112, 113) is identical and mounted independently of each other. As each capsule has a female and a male connector in the circumference an adaptor is needed between the bottom pumping capsule 14 a and the bottom bioreactor capsule (111) to compensate for the fact that the bottom pump in capsule (14 a) is turned. opposite. Each of the two pumping capsules 14 a, 14 b have four identical valves (12 a, 13 a) and external ports (12, 13) (only half is visible) through the circumference and internal port to the diaphragm (11) fluid volume (11 a). Further the pumping capsules (14 a, 14 b) house two integrated valves, which operate fully independently of each other in the capsule centre and connect the diaphragm volume to any other capsule fluid interface. All six valves in each pumping capsule (14 a, 14 b) operate fully independently of each other and are pneumatically controlled from the PCB below the diaphragm. More details are seen in FIG. 2.
  • No sensors are shown in FIG. 1, but all sensors present are preferably of single-use capabilities. The illustrated set-up will work excellent in perfusion mode, when connected to an external supply of fresh media as well as to the purification devices. No external pumps are needed as the two integrated diaphragm pumps also handle the external circulation of fluids.
  • FIG. 2 illustrates a preferred embodiment of a pumping capsule in 3D perspectives with the major four parts drawn apart from each other for better understanding. The same pumping capsule is also seen in FIGS. 1 and 9 in the present text.
  • Pump capsule primary disposable parts are:
  • 1. rigid upper housing parts (20 a) with four external media clamp connector flanges
  • 2. rigid lower housing part (20 b)
  • 3. at least one flexible diaphragm (21)
  • 4. four circumference tube sleeve valves of which (22 a) and (23 a) is visible
  • 5. one set of end-face mounted sleeve rubber body valves
  • 6. fluid control devices such as actuators for valves on PCB (60 d)
  • Control capsule cover (20 c) primary (not disposable) parts are:
  • 1. micro processor and general electronics
  • 2. sensors and their interface
  • 3. pneumatic valves for control of six sleeve valves invisible under cover
  • 4. proportional pneumatic valves (27 c, 27 c)
  • 5. vacuum ejector pump (27)
  • 6. connection for external supply of pressurized air, power supply and control interface
  • The pump capsule shell (20 a) is a disposable housing parts manufactured from plastics. At least one circular end-face integrated dual element valve (29) with dimensions according to the purification capsules platform including both inlet and outlet. As to the advantage of fluid communication with purification and/or other capsules the axial dual Naive elements (29 a, 29 b) opens or closes according to need for fluid access from the capsules connected to internal fluid volume (21 a). The upper housing part facilitate the central valve embodiment (29) and several valve embodiments (22 a, 23 a) pointing perpendicular to the central axis from said concave pumping chamber (21 a) to the circumference of the upper housing part (20 a) for external fluid communication. The valve bodies is elastic tube sleeves (23 b), which inflated by pneumatic pressure added to outer side of the tube sleeve, force the tube to collapse around a central core part (23 c) locking for any fluid flow through the valve. The lower housing part (20 b) supports mechanically the pumping diaphragm (21) during maximum inflation with a concave upper housing part (20 a) with the lower housing part (20 b) for deflation further facilitating support for at least one displacement sensor (24), pressure sensor(s), and temperature sensor. Displacement sensor (24) based on laser principles able to measure the distance to and the position of the membrane (21) and absolute pressure sensors based on micro electronics, both with a flexible transparent window on the wall in order to separate the two different environments.
  • The control capsule (20 c) contains on the circuit board (20 d) the entire package of electronics, sensors and controls. Proportional valve(s) for diaphragm control, on/off valves for the tube sleeve valves, and micro processor including connections the driving gas inlet/outlet on the circumference.
  • FIG. 3 illustrates a preferred embodiment of a bioreactor capsule to be placed in a column. The bioreactor matrix disc capsules is situated inside a stackable capsule device (30) of rigid disposable materials with at least one fluid inlet (32 a) and a series of symmetrically placed fluid outlets (32 b) integrated axially within the design of capsules (30). Four radial oriented fluid outlet ports (32 b) are connected to drainage collection volume (33) at the capsules periphery. The bioreactor capsule design comprises at least one set of matrix discs (31) and as here illustrated five sets of matrix discs (31). No flow spacers at the feed (32 a) and drainage (35 b) volumes between matrix discs (31) are shown for simplicity. Drainage spacers are connected to drainage collected volume (33) but not connected to the inlet volume (32) due to the presence of ring (35 d). Feed spacer volume (35 a) is not able to convey fluid to the circumference drainage collection volume (33) due to the presence of ring (35 c). The fluid is forced to be transported from inlet volume (32) to discs (31) at its edge by ring (35 d) and also restricted from exiting the discs (31) to the collection volume (33) by ring (35 c). The forced fluid flow is introduced at one of two inlet (32 a) filling up the inlet volume (32), and distributed to four full size and two half size feed spacer entrance (35 a) radial filling the feed spacer volume by laminar flow at overpressure flowing perpendicular to the entire surface area of at least one matrix disc. The fluid then flows through the disc (31) to the drainage spacer volume (35 b) and then further radial into the circumference collection volume (33), to be conveyed to end face collection volume (36) and outlet (32 b).
  • More than one bioreactor capsule may be mounted on top of each other and work in parallel and be sealed by (30 a) covering both inlet (32 a) and exit (32 b).
  • After the fluid has passed said bioreactor capsules the fluid may optionally pass further to at least one pumping capsule, a conditioning capsule, a separation capsule, etc. The illustrated capsules is 442 mm in diameter, one UH high=256 mm high, but may take other dimensions, which may be required, and offer approx. 16 litre of matrix volume.
  • FIG. 4 illustrates a preferred embodiment of a down stream processing capsule (40) comprising a number of traditional fibre based depth filter thin discs (41) oriented in sets angled to each other. In the present example eighteen identical discs (41) are positioned inside the capsule (40). On the circumference eight double step latches (not shown) are mounted and spread symmetrically around the capsule circumference for capsule assembling, which makes it easy to tightly keep the capsules together. Two dual fluid connections (42 a, 42 b) one at each end face are incorporated for connection to the neighbouring capsules. Fluid from the vertical inlet volume (42) guides flow through perforated tube (42 c) to the inlet volume of the depth filter discs (41). Circumference collection volume for drainage fluids guides liquid to either of the end face flanges and through port (42 b).
  • FIG. 5 illustrates a preferred embodiment of a manifold capsule (50) having four identical expandable tube sleeve valves (56 a, 56 c), (56 b and 56 d are inside tubes in the capsule and hence not shown), which are operated by pressurized air supplied by a pump unit (not shown) via hoses (52 h). On/off valves (not shown) either close or leave the valves open. Two external tri-clamp flanges connections (52 a, 52 b) are connected with the centre tube (55) and the other two flanges (52 c, 52 d) are connected with the fluid ring slot (54) around the centre tube (55). A rubber seal (57) insure leakage free connection to the interface similar neighbouring platform capsules.
  • FIG. 6 illustrates one embodiment of designing a conditioning capsule (60) with heating capabilities. The electrical heating elements are fully covered with approved materials and formed into four heating discs (61 a, 61 b, 61 c, 61 d) with fluid contact on each side, divided into two set (61 a, 61 b) and (61 c, 61 d) of discs in order to increase surface contact to the fluid that passes. Optionally the specific surface roughness or sets of ribs may be introduced in order to increase contact area and guide the fluid direction. Though in this version multiple circular slots (65) for fluid passage in the heating discs (61 a, 61 b, 61 c, 61 d) insures improved turbulence and contact between fluid and heating element discs. All heating discs (61 a, 61 b, 61 c, 61 d) are connected electrically to the plug (64) on the outside of the circumference of the capsule (60). Preferably at least one of the heating discs has a temperature sensor element integrated. Fluid inlet (61 a) and fluid outlet (61 b) may be interchanged, i.e. in some embodiments the fluid may enter the capsule through (61 b) and leave the capsule through (61 a). Two extra tri-clamps ports (63 a, 63 b) allow for various connections.
  • FIG. 7 illustrates one embodiment of designing a conditioning capsule (70) with symmetrically end face fluid connections and cooling capabilities. The stacked non porous wall tube heat exchanger coils (71) are located inside the capsule (70) with tube connection via two integrated tri-clamp flanges (74 a, 74 b) on the outside of the circumference of the capsule. The fluid flow path is labyrinth fluid flow created by three flat discs (75) between the coils. Two discs fixed to the centre inlet perforated tube, one disc fixed to the capsule circumference. Fluid inlet (71 a) is used on both sides to convey the fluid. Two extra tri-clamps (73 a, 73 b) allow for sensor connections. Either the tradition B.Braun type of 025 mm sensors or with a PG13.5 thread to tri-clamp adaptor also the smaller and more common 12 mm sensors become applicable. The capsule will also work as a sparging capsule (preferably combined with a bioreactor capsule with a need for oxygenation) with porous tubes coiled as shown and pressurized gases like air or oxygen inside the tube.
  • FIG. 8 shows a preferred embodiment of a capsule concept, which by design is suitable for several purposes, such as for various surface filtration and separations or diffusion purposes. A series of parallel oriented semi permeable tubes or hollow fibres arranged tightly packed and at each end attached gas tight within, integrated within two (such as epoxy or the like) end covers leaving all the fibres open in each end. The complete unit fitted inside the capsule platform.
  • In the present illustration the capsule is an oxygenation capsule (80), which may be incorporated for the purpose of real-time adjustment of the oxygen content in the media as dissolved oxygen and/or as micro bubbles. The shown capsule integrates a capsule (81) for oxygen introduction, which is short and quite wide. The circular design is easy to integrate in the round capsule (80). Oxygen or air pressure is applied from the circumference and surrounds the multiple gas-permeable hoses/tubes/fibres (81 a) between the epoxy end faces (81 b, 81 c) and gas exchange, diffusion takes place through the fibre wall with the fluid in both directions. The media flows in axial direction with inlet from any of the end faces to the distribution chamber with access to the numerous numbers of gas-permeable tubes. The fluid are forced by pumping actions through the tubes to the opposite side and into collection chamber and further conveyed to the exit flange. Two connection flanges (83 a, 83 b) allow connection to valves (not shown) preferably controlled by the pumping capsules of either pneumatic or electric character. This feature makes it possible to adjust, in real-time, the supply of various gases and in particular oxygen, and the adjustment is controlled from within the column. The shown capsule offers a maximum of 5.7 m2 surface area from 4,000 single hollow fibres tubes each being 5 mm and 90 mm long effective. The figure shows one single gas-permeable hoses/tube/fibre capsule, but in case of a relatively large diameter the capsule could be made up of a number of smaller units placed in parallel within the same capsule.
  • FIG. 9 shows an embodiment of the invented bio factory capsules stacked into a column (90) including the individual capsules as described above. The column comprises two bioreactor capsules (912, 913) similar to the capsule shown in FIG. 3, one down stream processing capsule (97) similar to the capsule shown in FIG. 4, three pumping capsules (94 a, 94 b, 94 c) similar to the capsule shown in FIG. 2, two conditioning capsules (95, 96) similar to the capsules shown in FIGS. 6, 7 and 8, respectively, and one manifold capsule (98) similar to the capsule shown in FIG. 5. The biofactory in FIG. 9 provides unlimited methods of use and includes specific connections in form of short hoses outside the stack between capsules, which facilitate the desired flow distribution along the column (90). An appropriate number of the capsules are equipped with external fluid connection flanges of tri-clamp design on the circumference. The illustrated set-up is appropriate for mammalian cell cultivation.
  • The column contains nine capsules and has a height of approx 1.7 meter. The single-use capability capsules are of identical diameter and platform concept in order to provide simple interconnection. The capsules are preferably designed in several different chassis heights in order to permit incremental capacity increase. Most of the capsules are able to perform bottom-up, to-down, bottom-in, and bottom-out. The easily interchangeable capsules in the bioreactor of FIG. 9 are:
  • 1. Bioreactor capsules (911, 912)
  • 2. Pumping capsules (94 a, 94 b, 94 c)
  • 3. Diffusion capsule for gas exchange and pH regulation (95)
  • 4. Conditioning capsule (96) including three ports for additional sensors (96 a)
  • 5. Down stream processing capsule—in this example being one depth filtration capsule (97)
  • 6. Manifold capsule (98)
  • The two bioreactor capsules (911, 912) are stacked on top of and next to the diffusion capsule (95) and together with the capsule below, (i.e. the temperature, fresh media and extra gas conditioning capsule 96), the passive production unit is provided. Below the temperature conditioning capsule 96 the pumping capsule 94 a completes the active production unit, which is capable of operating independently of the down stream processing unit, which is made up of a down stream processing capsule (97) and a manifold capsule (98) and a pumping capsule (94 c). On the circumference of the diffusion capsule (95) is mounted two flanges (95 a, 95 b) for access to gases such as CO2, air, and oxygen from an external supply to the inner core consisting of a hollow fibre capsule (95 c). Fresh media in diluted or concentrated form may be introduced via one of several ports on either side of the conditioning capsules controlled by a valve. The two pumping capsules (94 a, 94 b) are able to service unlimited tasks of fluid communication requirements internal in the production unit as well as with external devices or any combinations thereof.
  • The down stream processing unit consist in the present illustration of one depth filtration capsule (97) on top of one manifold capsule (98) combined with one pumping capsule (94 c). This independent down stream processing unit is operational on stand alone conditions also outside the FIG. 9 column. For simplicity only one down stream processing capsule (97) is shown. It is, however, possible to include several down stream processing capsules driven by the pump within the same column. Aseptic connection of two or more columns is done by sterile hoses externally via the generous use of tri-clamp flanges in order to perform the desired procedure of operation (not shown—see FIG. 10).
  • FIG. 10 shows a circuit diagram of the assembly in FIG. 9. Preferably all capsules integrate single-use sensors for monitoring at least oxygen temperature and pH values. The extra tri-clamp flanges on some capsules facilitate the use of any sensor.
  • The present figure illustrates the integration principle of the bioreactor capsule (101), which on the reactor top is connected to a in bottom-up position pumping capsule (104 b) and on the reactor bottom side is connected to two conditioning capsules (105, 106), which are further connected to one pumping capsule 104 a. On the rear side of each pumping capsules a pump control valve is located, which is shown as a wide black cross. Any of the interconnected pumping capsules (104 a, 104 b, 104 c) is able to work simultaneously, in tandem, individually and without any restriction in timing and reasonable flow capability. The manifold capsule (108) is controlled by the pumping capsule (104 c) control unit. Below the down stream processing capsule (107) a manifold capsule (108) connects the down stream processing capsule (107) with a port for drainage of product through valve (109 b). The inlet to the down stream processing capsule (107) is positioned centrally at top of pumping capsule (104 c) through the central of the manifold capsule (108). All fluid is fed through the pumping capsule (104 a). Air drainage during start up is done through valve on pumping capsule (104 b) via port (109 k).
  • Fresh nutrient liquid is added through valve (109 a) and sucked into the pump chamber of pumping capsule (104 a), as the diaphragm is deflated, from an external volume corresponding to the product volume drained under pressure from pump (104 c) through port (109 b).
  • The dual in-line valve (109 c) of the centre of pumping capsule (104 a) conveys the main nutrient flow pressurized by inflating diaphragm in (104 a) through the conditioning capsules (106) and (105) to the bioreactor capsule (101). Then the fluid passes the bioreactor (101) from inside volume (109 d) to the circumference collection volume (109 e) passing and through dual central valve (109 f) located in pumping capsule (104 b) while simultaneously the diaphragm in pumping capsule (104 b) is deflated.
  • Inside the bioreactor (101) the flow is conveyed in a radial flow pattern from the central core inlet (109 d), through the matrix discs for collection at the circumference volume (109 e) and directed through the ring inlet valve part of dual central valve (109 f) located in the pumping capsule (104 b).
  • Nutrient liquid is re-circulated from pumping capsule (104 b) through tube (109 g) on the right side of bioreactor (101) to pumping capsule (104 a) through an inlet valve, and the flow pattern as described above is repeated.
  • The down stream processing capsule (107) only collects a small amount of active micro organisms, because the majority of micro organisms are anchored in the bioreactor capsules (101). The down stream processing capsule (107) collects continuously dead cells and other particles as to the perfusion mode circulation and allows the purified product to pass.
  • A selected fraction of the retentate volume may be drained via drainage valve (109 b) directly from down stream processing capsule (107), the retentate fluid volume being equivalent to the fresh nutrient volume being added at (109 a). At desired sequences pumping capsule (104 b) will direct fluid to pumping capsule (104 c) through tube line (109 h) and through central valve (109 i), which forces the fluid to pass the down stream processing capsule (107) to drainage valve (109 b) as product.
  • The conditioning capsule (105) receives pressurized sterile gases to be dissolved, and sparged into the fluid through valve (109 j). The cross-flow conditioning capsule (106) contains temperature conditioning devices to insure correct bioreactor temperature.
  • Seeding with micro organism is done after the column is completely filled with media. The fluid is conditioned by re-circulation of the fluid for some time, which will insure collection of entrapped gas to be emptied via port (109 k) by allowing pump (104 a) or (104 b) to suck the culture media into the pumping chamber and force the seeding fluid up through the conditioning capsule into the bioreactor for anchoring. Alternatively the seeding is performed through (109 m) into pump (104 b) and reversed directly down through centre of dual valve (109 f) into the centre volume (109 d) of bioreactor capsule (101).
  • The single-use, pre-sterilized, disposable capsule devices, which are assembled in column configuration, provides significant product expression improvements, very small foot-print, low-cost investment, elimination of CIP, SIP and offer easy of use. Further all capsules communicate with the common PLC for the whole stack with several close loop control algorithms performing the desired routines.

Claims (21)

1-31. (canceled)
32. A bioreactor factory device comprising a production unit for cultivating biological cells and for producing one or more chemical compounds, said production unit comprising at least three interconnected and stacked capsules, wherein said at least three capsules of the production unit is a bioreactor capsule, a first pumping capsule, which is a capsule integrated reciprocating diaphragm pump based on single-use materials and a second pumping capsule which is a capsule integrated reciprocating diaphragm pump based on single-use materials, wherein the first pumping capsule is positioned as the top capsule and the second pumping capsule is positioned as the bottom capsule in the stack of the production unit, said first pumping capsule and said second pumping capsule being in operable and liquid contact with each other and capable of regulating liquid to and from said bioreactor capsule.
33. The bioreactor factory according to claims 32, wherein the production unit further comprises at least one conditioning capsule located at any position between the first and the second pumping capsule.
34. The bioreactor factory according to claim 33, wherein at least one of the conditioning capsule(s) is a temperature regulating capsule.
35. The bioreactor factory according to claim 34, wherein at least one of the conditioning capsule(s) is a diffusion capsule.
36. The bioreactor factory claim 32, wherein the bioreactor factory is for single use.
37. The bioreactor factory according to claim 32, wherein the bioreactor factory device also comprises a down stream processing unit, said down stream processing unit comprising at least one down stream processing capsule and at least one pumping capsule which is a capsule integrated reciprocating diaphragm pump based on single-use materials.
38. The bioreactor factory according to claim 37, wherein the production unit is positioned on top of the down stream processing unit and where a pumping capsule which is a capsule integrated reciprocating diaphragm pump based on single-use materials, is positioned as the bottom capsule of the down stream processing unit.
39. The bioreactor factory according to claim 37, wherein the down stream processing unit is positioned on top of the production unit and where a pumping capsule which is a capsule integrated reciprocating diaphragm pump based on single-use materials, is positioned as the top capsule of the down stream processing unit.
40. The bioreactor according to claim 37, wherein the down stream processing capsule is selected from the group consisting of a membrane filtration capsule, a separation capsule, an ion exchange capsule, a purification capsule, a chromatography capsule, an activated carbon capsule, and a packed bed capsule.
41. The bioreactor according to claim 37, wherein the down stream processing capsule comprises a flow-through matrix made up of a number of tubes through which the liquid to be processed is flowing.
42. The bioreactor according to claim 32, wherein the capsules are further provided with interlocking interface areas for exchange of fluid, electrical signals, electrical power, pneumatic signal exchange and/or vacuum signal exchange.
43. The bioreactor according to claim 32, wherein the capsules are further provided with interlocking means, such as latches, for keeping together the capsules in the stack.
44. The bioreactor according to claim 32, wherein the capsules are further provided with sealing arrangements on each side of the capsules for insuring sterile handling before stacking and interconnecting the capsules.
45. The bioreactor according to claim 32, wherein the capsules in the stack are placed in the horizontal position next to one another.
46. The bioreactor according to claim 32, wherein the stack of capsules are placed in the upright position vertical to one another.
47. A down stream processing unit comprising at least two interconnected and stacked capsules, wherein said at least two capsules are one down stream processing capsule and one pumping capsule which is a capsule integrated reciprocating diaphragm pump based on single-use materials.
48. The down stream processing unit according to claim 47, wherein the down stream processing unit comprises at least a down stream processing capsule, a first pumping capsule which is a capsule integrated reciprocating diaphragm pump based on single-use materials and a second pumping capsule which is a capsule integrated reciprocating diaphragm pump based on single-use materials, wherein the first pumping capsule is positioned as the top capsule and the second pumping capsule is positioned as the bottom capsule in the stack of the down stream processing unit, said first pumping capsule and said second pumping capsule being in operable and liquid contact with each other and capable of regulating liquid to and from said down stream processing capsule.
49. The down stream processing unit according to claim 47, wherein the capsules are selected from the group consisting of pumping capsules which is a capsule integrated reciprocating diaphragm pump based on single-use materials, separation capsules, filtration capsules, chromatography capsules, ion exchange capsules, storage capsules, conditioning capsules, sparging capsules, diffusion capsules, manifold capsules, valve capsules, column end capsules, and any combinations thereof, and wherein said capsules are capable of being stacked individually in any order and any number, with the proviso that the top capsule and the bottom capsule in the column must be pumping capsules which are capsules integrated reciprocating diaphragm pump based on single-use materials.
50. A method for cultivating microorganisms and producing a chemical compound by use of a biochemical reaction taken place in the bioreactor according to claim 32.
51. The method for processing liquid from a bioreactor by use of a down stream processing unit according to claim 47.
US13/125,430 2008-12-19 2009-12-18 Biopharmaceutical plant in a column Abandoned US20110236932A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
DKPA200801815 2008-12-19
DKPA/2008/01815 2008-12-19
DKPA200901131 2009-10-19
DKPA/2009/01131 2009-10-19
DKPA200901142 2009-10-21
DKPA/2009/01142 2009-10-21
DKPA200901165 2009-10-29
DKPA/2009/01165 2009-10-29
PCT/DK2009/000260 WO2010069320A2 (en) 2008-12-19 2009-12-18 Biopharmaceutical plant in a column

Publications (1)

Publication Number Publication Date
US20110236932A1 true US20110236932A1 (en) 2011-09-29

Family

ID=42025700

Family Applications (5)

Application Number Title Priority Date Filing Date
US13/125,430 Abandoned US20110236932A1 (en) 2008-12-19 2009-12-18 Biopharmaceutical plant in a column
US13/125,900 Abandoned US20110223581A1 (en) 2008-12-19 2009-12-18 Electronically controlled diaphragm pump
US13/125,399 Active 2032-07-14 US9228579B2 (en) 2008-12-19 2009-12-18 Method and device for industrial biolayer cultivation
US14/945,219 Active US10288060B2 (en) 2008-12-19 2015-11-18 Electronically controlled diaphragm pump
US16/171,720 Active US10508647B2 (en) 2008-12-19 2018-10-26 Electronically controlled diaphragm pump

Family Applications After (4)

Application Number Title Priority Date Filing Date
US13/125,900 Abandoned US20110223581A1 (en) 2008-12-19 2009-12-18 Electronically controlled diaphragm pump
US13/125,399 Active 2032-07-14 US9228579B2 (en) 2008-12-19 2009-12-18 Method and device for industrial biolayer cultivation
US14/945,219 Active US10288060B2 (en) 2008-12-19 2015-11-18 Electronically controlled diaphragm pump
US16/171,720 Active US10508647B2 (en) 2008-12-19 2018-10-26 Electronically controlled diaphragm pump

Country Status (3)

Country Link
US (5) US20110236932A1 (en)
EP (3) EP2379699B1 (en)
WO (3) WO2010069319A2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140271571A1 (en) * 2013-03-15 2014-09-18 Sage Science, Inc. Cell Culture Cassettes and Incubator
WO2015003012A3 (en) * 2013-07-01 2015-11-26 Olivier Berteau Distributed perfusion bioreactor system for continuous culture of biological cells
WO2016044758A1 (en) * 2014-09-19 2016-03-24 Therapeutic Proteins International, LLC Harvesting and purification or perfusion yielder (happy) device
US20160097073A1 (en) * 2014-10-06 2016-04-07 Therapeutic Proteins International, LLC Purification and separation treatment assembly (pasta) for biological products
US9969966B2 (en) 2011-05-30 2018-05-15 Atech Partners Limited Bioreactor system for continuous cell cultivation
US10288060B2 (en) 2008-12-19 2019-05-14 Stobbe Pharma Tech Gmbh Electronically controlled diaphragm pump
US20190367858A1 (en) * 2018-06-01 2019-12-05 Lonza Ltd. Midscale Model For Organic Growth and Phasing
US10755210B2 (en) * 2014-08-15 2020-08-25 Ecolab Usa Inc. CIP wash summary and library
US20210267150A1 (en) * 2020-01-24 2021-09-02 Australis Aquaculture, Llc Bioreactor And Method For Culturing Seaweed
US20220249758A1 (en) * 2021-02-08 2022-08-11 Dongxu Zhang Blood cleaning device

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1016793A4 (en) 2005-10-04 2007-06-05 Artelis CELL CULTURE METHOD AND DEVICE FOR CARRYING OUT SAME
US7940188B2 (en) * 2008-02-07 2011-05-10 Veltek Associates, Inc. Air sampling system having a plurality of air sampling devices with their own flow switches
US20100233353A1 (en) * 2009-03-16 2010-09-16 Applied Materials, Inc. Evaporator, coating installation, and method for use thereof
CN104390816B (en) * 2010-02-18 2018-01-23 威尔泰克联合股份有限公司 improved air sampling system
WO2011161088A2 (en) * 2010-06-23 2011-12-29 Stobbe Tech. A/S Biopharmaceutical process apparatuses assembled into a column
US8974200B2 (en) * 2011-07-08 2015-03-10 International Business Machines Corporation Device for creating fluid flow
EP2557407B1 (en) * 2011-08-12 2020-02-12 Fenwal, Inc. A blood processing system and method
NL2007734C2 (en) * 2011-11-07 2013-05-08 Tulip Life Science Products B V DEVICE FOR GROWING CELLS.
CN103217319B (en) * 2012-01-19 2017-05-17 深圳迈瑞生物医疗电子股份有限公司 Sampling pump and gas analyzer
WO2013112961A1 (en) * 2012-01-27 2013-08-01 Aiken Brian L Fluid treatment system
EP2864469A4 (en) * 2012-06-21 2016-05-18 Neostem Oncology Llc Bioreactor cartridge and system
US9051183B2 (en) 2012-08-24 2015-06-09 Intelligent Energy Inc. Hydrogen generator having reactant pellet with concentration gradient
JP2016531578A (en) * 2013-08-27 2016-10-13 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ Bioreactor with addition tube
EP3055133B1 (en) 2013-10-11 2019-12-04 Advanced Solutions Life Sciences, LLC System and workstation for the design, fabrication and assembly of bio-material constructs
CN103642680A (en) * 2013-12-06 2014-03-19 浙江工业大学 Built-in disc fibrous bed reactor for fermenting production of butyric acid
US10022268B2 (en) * 2013-12-17 2018-07-17 Medical Instrument Development Laboratories, Inc. Diaphragm-position-controlled, multi-mode ocular fluid management system and method
US20160072738A1 (en) * 2014-09-08 2016-03-10 Grant Patrick Henderson System and methods for electronic communication between business entities
US10384156B2 (en) 2014-09-12 2019-08-20 Hollingsworth & Vose Company Filter media comprising fibers including charged particles
WO2017019514A1 (en) * 2015-07-24 2017-02-02 Bioreactor Sciences Llc Horizontally rocked bioreactor system
EP3331983A1 (en) 2015-08-08 2018-06-13 Stobbe Pharma Tech GmbH Disposable bioprocess system supporting biological activity
US10077422B2 (en) * 2015-09-28 2018-09-18 The University Of Toledo Microalgae harvesting using stimuli-sensitive hydrogels
WO2017066252A1 (en) * 2015-10-13 2017-04-20 Hyperloop Technologies, Inc. Adjustable variable atmospheric condition testing apparatus and method
US20170218943A1 (en) * 2016-01-29 2017-08-03 Ramparts, Llc Controller for pump system
EP3199616A1 (en) 2016-01-29 2017-08-02 Eppendorf Ag Disposable connection device
EP3420068A1 (en) * 2016-02-23 2019-01-02 Corning Incorporated Perfusion bioreactor and method for using same to perform a continuous cell culture
US11454563B2 (en) * 2016-08-05 2022-09-27 Encite Llc Micro pressure sensor
US11708285B2 (en) * 2016-08-18 2023-07-25 National Machine Company Scale reduction cartridge system
US20180057784A1 (en) 2016-08-27 2018-03-01 3D Biotek, Llc Bioreactor
BE1024733B1 (en) 2016-11-09 2018-06-14 Univercells Sa CELL GROWTH MATRIX
US10590374B2 (en) * 2017-06-23 2020-03-17 Timothy Ray Ho Automatic multi-tray and multi-plate bioreactor systems for adherent cultures
BR112020012574A2 (en) * 2017-12-20 2020-11-24 Univercells Technologies S.A. bioreactor and related methods
IL256431B (en) * 2017-12-20 2022-02-01 Viktorov Alexandr System for growing living organisms
US10792594B2 (en) * 2017-12-28 2020-10-06 Replegin Corporation Dual pumping arrangement for a hollow fiber filter
US10932072B2 (en) * 2018-05-01 2021-02-23 Analog Devices, Inc. Optical measurement of displacement
GB2573327B (en) * 2018-05-03 2021-05-12 Mosa Meat Bv Apparatus and process for production of tissue from cells
CN108315259B (en) * 2018-05-09 2024-01-23 武汉赛科成科技有限公司 Fluidized bed cell culture disposable membrane device filled with sheet-shaped carrier
EP3830235A1 (en) * 2018-07-27 2021-06-09 Univercells Technologies S.A. System and method for the production of biomolecules
EP3861098A4 (en) * 2018-10-01 2022-07-06 Membio Inc. Cell culture bioreactor
US10975777B2 (en) 2018-10-01 2021-04-13 Hamilton Sunstrand Corporation Fuel metering unit
US11661576B2 (en) 2019-02-05 2023-05-30 Corning Incorporated Packed-bed bioreactor systems and methods of using the same
FR3094762B1 (en) * 2019-04-05 2021-04-09 Pfeiffer Vacuum Dry type vacuum pump and pumping installation
CN114127419A (en) 2019-07-12 2022-03-01 艾本德欧洲股份公司 Control device and method for controlling a sensorless diaphragm pump
WO2021010892A1 (en) * 2019-07-15 2021-01-21 National University Of Singapore A ceramic membrane for water and wastewater treatment
US10935176B1 (en) 2019-09-03 2021-03-02 Loon Llc Multi port fluid connector
US11378309B2 (en) * 2019-10-08 2022-07-05 B/E Aerospace, Inc. Multi-stage vortex tube assembly for low pressure and low flow applications
US11118151B2 (en) 2019-11-05 2021-09-14 Corning Incorporated Fixed bed bioreactor and methods of using the same
EP3835407A1 (en) * 2019-12-11 2021-06-16 Sartorius Stedim Biotech GmbH Tubular biomanufacturing assembly
CN111537280B (en) * 2020-04-09 2023-04-07 南京万德斯环保科技股份有限公司 Diaphragm non-standard pipe liquid pumping system and method
CN111518693A (en) * 2020-04-30 2020-08-11 王家文 Rotary radial spreading axial multi-sheet adherent cell culture device
CN111518692B (en) * 2020-04-30 2023-07-28 广东康盾创新产业集团股份公司 Automatic human stem cell culture instrument
WO2022038295A1 (en) * 2020-08-21 2022-02-24 Univercells Technologies S.A. Biomass measuring system for fixed bed bioreactor and related methods
CN117561324A (en) * 2021-05-03 2024-02-13 康宁股份有限公司 Fixed bed bioreactor for cell culture and harvesting and related methods
WO2023009373A1 (en) * 2021-07-30 2023-02-02 Corning Incorporated Uniform cell culture substrate for fixed bed bioreactor
WO2023009374A1 (en) * 2021-07-30 2023-02-02 Corning Incorporated Uniform cell culture substrate for fixed bed bioreactor
WO2023194597A1 (en) * 2022-04-07 2023-10-12 Univercells Technologies Sa Modular bioreactor, bioreactor system and related methods

Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201845A (en) * 1976-04-12 1980-05-06 Monsanto Company Cell culture reactor
US4514499A (en) * 1983-02-04 1985-04-30 Corning Glass Works Cell culture using a monolithic support
US4546083A (en) * 1983-04-22 1985-10-08 Stolle Research & Development Corporation Method and device for cell culture growth
US4789634A (en) * 1985-06-18 1988-12-06 Dr. Muller-Lierheim Kg Biologische Laboratorien Carrier for the cultivation of human and/or animal cells in a fermenter
US4937196A (en) * 1989-08-18 1990-06-26 Brunswick Corporation Membrane bioreactor system
US4948728A (en) * 1985-09-03 1990-08-14 California Institute Of Technology Monolith reactor containing a plurality of flow passages and method for carrying out biological reactions
US4978616A (en) * 1985-02-28 1990-12-18 Verax Corporation Fluidized cell cultivation process
US5266476A (en) * 1985-06-18 1993-11-30 Yeda Research & Development Co., Ltd. Fibrous matrix for in vitro cell cultivation
US5362622A (en) * 1993-03-11 1994-11-08 Board Of Regents, The University Of Texas System Combined perfusion and oxygenation apparatus
US5501971A (en) * 1993-01-29 1996-03-26 New Brunswick Scientific Co., Inc. Method and apparatus for anchorage and suspension cell culture
US5543047A (en) * 1992-11-06 1996-08-06 Pall Corporation Filter with over-laid pleats in intimate contact
US5563069A (en) * 1992-04-24 1996-10-08 The Ohio State University Research Foundation Extractive fermentation using convoluted fibrous bed bioreactor
US20040048366A1 (en) * 2000-05-13 2004-03-11 Norbert Stroh Reactor module with capillary membranes
US20040132175A1 (en) * 2000-07-19 2004-07-08 Jerome Vetillard Cell culture chamber and bioreactor for extracorporeal culture of animal cells
US6844187B1 (en) * 1999-07-12 2005-01-18 Sefar Ag Bioreactor
US20050158851A1 (en) * 2004-01-12 2005-07-21 Bioreactor Systems And Disposable Bioreactor Bioreactor systems and disposable bioreactor
US20080003676A1 (en) * 2006-06-26 2008-01-03 Millipore Corporation Growth of embryonic stem cells
US20080131957A1 (en) * 2006-11-30 2008-06-05 Ryan John A Disposable spinner flask
US20080248552A1 (en) * 2005-10-04 2008-10-09 Artelis Method of cell cultures and device for implementing it
US20090176301A1 (en) * 2007-07-12 2009-07-09 Oldenburg Kevin R Disposable spinner flask
US20090311776A1 (en) * 2008-06-11 2009-12-17 Millipore Corporation Stirred tank bioreactor

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3554672A (en) * 1968-01-10 1971-01-12 Gen Motors Corp Hot gas engine with accumulator type gas compressor
US3551076A (en) * 1968-03-22 1970-12-29 Interpace Corp Tubular diaphragm pump
DE1703545A1 (en) * 1968-06-07 1972-01-13 Siemens Ag Valve controlled differential pump
US3568214A (en) * 1968-07-24 1971-03-09 Univ Utah Artificial heart system and method of pumping blood by electromagnetically pulsed fluid
FR2510203A1 (en) * 1981-07-24 1983-01-28 Evrard Robert MEMBRANE DRY PRIMARY PUMP
US4494912A (en) * 1982-09-16 1985-01-22 Pauliukonis Richard S Energy conserving air pump
DE3409501A1 (en) 1984-03-15 1985-10-24 Sandoz-Patent-GmbH, 7850 Lörrach METHOD FOR CULTIVATING CELLS
EP0237666A1 (en) 1986-03-21 1987-09-23 David Dziewulski Membrane compartment biochemical reactor
IL83259A (en) 1987-07-20 1992-05-25 D F Lab Ltd Disposable cell and diaphragm pump for use of same
US4921792A (en) 1987-11-27 1990-05-01 Miles Inc. Continuous cell dispersion, cultivation and substance recovery process
DE3923279A1 (en) * 1989-07-14 1990-01-18 Will W Prof Dr Minuth MINUSHEETS IS A NEW PRODUCT FOR CULTIVATING CELLS IN ANY CONTAINERS IN A HIGHLY DIFFERENTIATED FORM ON THE MOST NATURAL DOCUMENT
GB9102410D0 (en) * 1991-02-05 1991-03-20 Blagdon Durham Ltd Pumps
US5249932A (en) * 1991-10-07 1993-10-05 Erik Van Bork Apparatus for controlling diaphragm extension in a diaphragm metering pump
US5252041A (en) * 1992-04-30 1993-10-12 Dorr-Oliver Incorporated Automatic control system for diaphragm pumps
US5257914A (en) * 1992-06-24 1993-11-02 Warren Rupp, Inc. Electronic control interface for fluid powered diaphragm pump
US5378122A (en) 1993-02-16 1995-01-03 Wilden Pump & Engineering Co. Air driven diaphragm pump
JP3083275B2 (en) * 1997-09-18 2000-09-04 株式会社ワイ・テイ・エス Double diaphragm pump
DE19826610A1 (en) * 1998-06-16 1999-12-23 Bran & Luebbe Diaphragm pump and device for controlling the same
SE514807C2 (en) 1998-09-10 2001-04-30 Svante Bahrton Double-acting diaphragm pump for constant pressure and flow
DE19940498A1 (en) * 1999-08-26 2001-03-22 Knf Neuberger Gmbh Diaphragm pump
US6544424B1 (en) * 1999-12-03 2003-04-08 Refined Technology Company Fluid filtration system
US6537033B2 (en) * 2000-04-11 2003-03-25 Western Dairies Incorporation Open loop control apparatus for vacuum controlled systems
US20040136843A1 (en) 2002-04-12 2004-07-15 Bayer Aktiengesellschaft Diaphragm pump
GB0219618D0 (en) 2002-08-22 2002-10-02 Battelle Memorial Institute Woundcare
EP1403519A1 (en) * 2002-09-27 2004-03-31 Novo Nordisk A/S Membrane pump with stretchable pump membrane
JP4680990B2 (en) 2004-06-04 2011-05-11 エクセラーエックス, インコーポレイテッド Disposable bioreactor system and method
WO2006122268A2 (en) 2005-05-10 2006-11-16 Pendotech Sanitary diaphragm pump for critical bioprocess applications
US8197231B2 (en) * 2005-07-13 2012-06-12 Purity Solutions Llc Diaphragm pump and related methods
US7717682B2 (en) * 2005-07-13 2010-05-18 Purity Solutions Llc Double diaphragm pump and related methods
SE529328C2 (en) 2005-11-15 2007-07-10 Johan Stenberg Control system and method for controlling electromagnetically driven pumps
JP4694377B2 (en) * 2006-01-27 2011-06-08 シーケーディ株式会社 Chemical supply system
WO2007142664A1 (en) 2006-06-08 2007-12-13 Amprotein Corporation A method to increase dissolved oxygen in a culture vessel
EP2465514A1 (en) * 2006-11-03 2012-06-20 Aastrom Biosciences, Inc. Mixed Cell Populations For Tissue Repair And Separation Technique For Cell Processing
WO2008101127A2 (en) * 2007-02-15 2008-08-21 Broadley-James Corporation Bioreactor jacket
EP2033765A1 (en) 2007-09-07 2009-03-11 Vem S.P.A. Mandrel for providing a tubular article
US8038640B2 (en) * 2007-11-26 2011-10-18 Purity Solutions Llc Diaphragm pump and related systems and methods
KR100932861B1 (en) * 2007-11-30 2009-12-21 코아스템(주) Cell culture flask
EP2379699B1 (en) 2008-12-19 2017-12-13 Stobbe Tech A/S Device for industrial biolayer cultivation

Patent Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201845A (en) * 1976-04-12 1980-05-06 Monsanto Company Cell culture reactor
US4514499A (en) * 1983-02-04 1985-04-30 Corning Glass Works Cell culture using a monolithic support
US4546083A (en) * 1983-04-22 1985-10-08 Stolle Research & Development Corporation Method and device for cell culture growth
US4978616A (en) * 1985-02-28 1990-12-18 Verax Corporation Fluidized cell cultivation process
US4789634A (en) * 1985-06-18 1988-12-06 Dr. Muller-Lierheim Kg Biologische Laboratorien Carrier for the cultivation of human and/or animal cells in a fermenter
US5266476A (en) * 1985-06-18 1993-11-30 Yeda Research & Development Co., Ltd. Fibrous matrix for in vitro cell cultivation
US4948728A (en) * 1985-09-03 1990-08-14 California Institute Of Technology Monolith reactor containing a plurality of flow passages and method for carrying out biological reactions
US4937196A (en) * 1989-08-18 1990-06-26 Brunswick Corporation Membrane bioreactor system
US5563069A (en) * 1992-04-24 1996-10-08 The Ohio State University Research Foundation Extractive fermentation using convoluted fibrous bed bioreactor
US5543047A (en) * 1992-11-06 1996-08-06 Pall Corporation Filter with over-laid pleats in intimate contact
US5501971A (en) * 1993-01-29 1996-03-26 New Brunswick Scientific Co., Inc. Method and apparatus for anchorage and suspension cell culture
US5362622A (en) * 1993-03-11 1994-11-08 Board Of Regents, The University Of Texas System Combined perfusion and oxygenation apparatus
US6844187B1 (en) * 1999-07-12 2005-01-18 Sefar Ag Bioreactor
US20040048366A1 (en) * 2000-05-13 2004-03-11 Norbert Stroh Reactor module with capillary membranes
US20040132175A1 (en) * 2000-07-19 2004-07-08 Jerome Vetillard Cell culture chamber and bioreactor for extracorporeal culture of animal cells
US20050158851A1 (en) * 2004-01-12 2005-07-21 Bioreactor Systems And Disposable Bioreactor Bioreactor systems and disposable bioreactor
US20080248552A1 (en) * 2005-10-04 2008-10-09 Artelis Method of cell cultures and device for implementing it
US20080003676A1 (en) * 2006-06-26 2008-01-03 Millipore Corporation Growth of embryonic stem cells
US20080131957A1 (en) * 2006-11-30 2008-06-05 Ryan John A Disposable spinner flask
US20090176301A1 (en) * 2007-07-12 2009-07-09 Oldenburg Kevin R Disposable spinner flask
US20090311776A1 (en) * 2008-06-11 2009-12-17 Millipore Corporation Stirred tank bioreactor

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10508647B2 (en) 2008-12-19 2019-12-17 Stobbe Pharma Tech Gmbh Electronically controlled diaphragm pump
US10288060B2 (en) 2008-12-19 2019-05-14 Stobbe Pharma Tech Gmbh Electronically controlled diaphragm pump
US9969966B2 (en) 2011-05-30 2018-05-15 Atech Partners Limited Bioreactor system for continuous cell cultivation
US9597355B2 (en) * 2013-03-15 2017-03-21 Sage Science, Inc. Cell culture cassettes and incubator
US20140271571A1 (en) * 2013-03-15 2014-09-18 Sage Science, Inc. Cell Culture Cassettes and Incubator
US10519411B2 (en) 2013-03-15 2019-12-31 Sage Science, Inc. Cell culture cassettes and incubator
US10214718B2 (en) 2013-07-01 2019-02-26 University Of Massachusetts Distributed perfusion bioreactor system for continuous culture of biological cells
WO2015003012A3 (en) * 2013-07-01 2015-11-26 Olivier Berteau Distributed perfusion bioreactor system for continuous culture of biological cells
US10755210B2 (en) * 2014-08-15 2020-08-25 Ecolab Usa Inc. CIP wash summary and library
US9701933B2 (en) 2014-09-19 2017-07-11 Sarfaraz K. Niazi Harvesting and purification or perfusion yielder (HAPPY) device
WO2016044758A1 (en) * 2014-09-19 2016-03-24 Therapeutic Proteins International, LLC Harvesting and purification or perfusion yielder (happy) device
US20160097073A1 (en) * 2014-10-06 2016-04-07 Therapeutic Proteins International, LLC Purification and separation treatment assembly (pasta) for biological products
US20190367858A1 (en) * 2018-06-01 2019-12-05 Lonza Ltd. Midscale Model For Organic Growth and Phasing
US20210267150A1 (en) * 2020-01-24 2021-09-02 Australis Aquaculture, Llc Bioreactor And Method For Culturing Seaweed
US11638406B2 (en) * 2020-01-24 2023-05-02 Australis Aquaculture, Llc Bioreactor and method for culturing seaweed
US20220249758A1 (en) * 2021-02-08 2022-08-11 Dongxu Zhang Blood cleaning device

Also Published As

Publication number Publication date
US9228579B2 (en) 2016-01-05
WO2010069320A3 (en) 2010-08-12
EP2379692B1 (en) 2012-12-05
US20160195081A1 (en) 2016-07-07
WO2010069321A3 (en) 2010-09-10
US10288060B2 (en) 2019-05-14
US20190063420A1 (en) 2019-02-28
EP2379889B1 (en) 2015-09-30
WO2010069319A2 (en) 2010-06-24
EP2379699B1 (en) 2017-12-13
WO2010069321A2 (en) 2010-06-24
US20110223581A1 (en) 2011-09-15
WO2010069319A3 (en) 2010-08-19
US20110263021A1 (en) 2011-10-27
WO2010069320A2 (en) 2010-06-24
EP2379889A2 (en) 2011-10-26
EP2379692A2 (en) 2011-10-26
US10508647B2 (en) 2019-12-17
EP2379699A2 (en) 2011-10-26

Similar Documents

Publication Publication Date Title
EP2379692B1 (en) Biopharmaceutical plant in a column
JP7298054B2 (en) Disposable bioprocess systems that support bioactivity
US20130196375A1 (en) Biopharmaceutical process apparatuses assembled into a column
US11225637B2 (en) Enclosed filtration system processes
KR101990651B1 (en) Fluid filtration systems
US20130115588A1 (en) Integrated bioreactor and separation system and methods of use therof
US8501460B2 (en) Bioreactor systems and disposable bioreactor
KR20190128546A (en) Bioreactor System and Method
KR20210069032A (en) Biomolecule production systems and methods
RU2340662C2 (en) Bioreactor with exposure in liquid and gas phases for cultivation of cells
JP6705725B2 (en) Cell separation device and culture device
KR20150004333A (en) Device, system and process for modification or concentration of cell-depleted fluid
US20230056468A1 (en) Retention system
US20230042475A1 (en) Disposable bioprocess system supporting biological activity
US20230098953A1 (en) Hollow fiber screening tool, system, and method

Legal Events

Date Code Title Description
AS Assignment

Owner name: STOBBE TECH A/S, DENMARK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:STOBBE, PER;REEL/FRAME:026163/0936

Effective date: 20110412

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION